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ABSTRACT 
PATTERNS OF WEIGHT CHANGE IN INFANTS WITH CONGENITAL HEART 
DISEASE FOLLOWING NEONATAL SURGERY: POTENTIAL PREDICTORS OF 
GROWTH FAILURE 
SHARON Y IRVING 
DISSERTATION SUPERVISOR: BARBARA MEDOFF-COOPER, RN, PhD 
 
Congenital heart disease (CHD) is reported to have an incidence of 9 to 14 per 
1000 live births with a prevalence estimated between 650,000 and 1.3 million persons 
in the United States (US). It is a structural malformation(s) of one or more heart 
chamber(s) and/or deformity of one or more of the major intrathoracic blood vessel(s) 
and the ensuing malady occurring during embryonic development. Up to one-third of 
infants with CHD, require surgical intervention. Improved surgical technique over the 
last several decades has seen an increased survival of neonates with CHD. 
Concomitantly there has been an emergence of co-morbidities. Growth failure is a 
common co-morbidity following neonatal surgery for CHD.  More than 30% of these 
infants fall below the third percentile for weight early in their lives.  Postsurgical 
physiology, disease severity, feeding dysfunction, and a hypermetabolic state may all 
contribute to growth failure, which has been associated with deficits in cognitive 
development, intellectual ability and neurodevelopment, effecting maturation and 
school performance.  Early recognition and intervention of growth failure can improve 
health outcomes. The objective of this work is to identify patterns of growth and growth 
failure in infants with CHD and explore potential predictors that may be modifiable to 
mitigate growth failure and prevent the associated untoward consequences.  
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INTRODUCTION 
Congenital heart disease (CHD) is defined as the structural malformation(s) of 
one or more heart chambers and/or deformities of the major intrathoracic blood vessels 
and the ensuing malady that occurs during embryonic development. The incidence of 
CHD reported to be 9 to 14 per 1,000 live births,1-3
 
has a prevalence estimated 
between 650,000 and 1.3 million persons in the United States (US).1,4,5 CHD accounts 
for as much as 50% of neonatal infant mortality and is considered to be the most 
common cause of infant death from a birth defect in the US.6 Up to one third of infants 
born with CHD require surgical intervention early in their lives.7 The Consortium of the 
Society of Thoracic Surgeons of Congenital Heart Surgery reported more than 60% of 
infants born between July 2004 and June 2008 presented for surgical intervention in 
the neonatal period (first 30 days of life).8 As a disease entity, CHD contributes not only 
to the rate of infant mortality and to the prevalence of infant morbidity, but also to 
chronic childhood health conditions and the associated healthcare costs.  
With improvement in surgical technique, medical treatment, and nursing care 
over the last few decades, there has been marked increase in the survival rate of 
neonates with CHD. Between 1979 and 1997, CHD-related mortality declined more 
than 39% in the US.1 Along with improved survival of neonates and infants undergoing 
surgery for CHD, there has been a parallel emergence of co-morbidities in the 
survivors. Although non-cardiac concomitant conditions requiring services from  
pediatric subspecialists such as neurologists, pulmonologists, and orthopedics are 
frequently seen,9 growth failure is one of the more common sequelae observed in 
infants with CHD.10-12 More than 50% exhibit poor growth early in life and 30% fall 
below the third percentile for weight on standard growth charts for age and gender 
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during infancy.13,14 The high prevalence of CHD, its contribution to infant morbidity and 
mortality and the association with poor growth in infancy are ongoing challenges in 
caring for these infants.  
Growth is fundamental to pediatric care and often used as a gauge to measure 
the infant’s health and well-being. For postsurgical infants with CHD, growth, 
particularly weight gain, may also be a measure of surgical success and disease 
management. Poor growth is common and well documented in infants with CHD both 
before and after surgical intervention.10-12,14-18 Historically, poor growth also described 
as growth failure has been ascribed to the population sample studied, making it difficult 
to quantify and more difficult to generalize.19,20 Recent data suggest suboptimal 
monitoring of growth measures, chronic medical problems that present with poor 
growth, and socioeconomic factors may all be associated with growth failure but are 
under-appreciated for their contribution to this condition.21,22 This may in part be 
responsible for lack of an all-encompassing definition for growth failure adding to the 
difficultly of diagnosis and treatment. Growth failure in infants with CHD can be the 
result of feeding dysfunction resulting in inadequate nutrient intake, hemodynamic 
alterations related to the underlying cardiac physiology, alterations in body 
composition, neurologic immaturity, intercurrent illnesses, or disease severity.  
There is no consensus on the definition of growth failure for infants and young 
children with CHD. The same primary cardiac diagnosis can present differently based  
on physiology and degree of hemodynamic impairment.  This variability affects weight 
gain and adds to the complexity of defining and identifying growth failure in this 
population.  
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Regardless of the etiology, growth failure can have a long-lasting effect on 
overall health. Poor growth has also been associated with poor cognitive development 
and deficits in neurodevelopmental outcomes that extend well into childhood and 
adolescence.23-27 Further investigation into potential contributing factors, physiologic 
associations, and possible modifiable elements that will lead to development of 
strategies and interventions to prevent and/or minimize growth failure in these infants 
will augment continued advances in surgical approach and improvements in care. A 
better understanding of growth failure and its contributing factors can lead to 
interventions to minimize or prevent its occurrence and improve health outcomes for 
these infants. An investigation into the pattern of growth in infants with CHD compared 
to healthy infants and exploring energy expenditure as a potential contributing factor to 
the poor growth often seen is the focus of this dissertation. For the purposes of this 
work, the terms ‘growth failure’ and ‘poor growth’ are synonymous and define the less 
than adequate growth described throughout. Table 1 is a definition of terms. 
 
 
 
 
 
 
 
 
 
 
 4 
 
CHAPTER 1 
The Problem: Growth Failure 
Understanding Growth and Growth Failure 
Whereas growth is fundamental to pediatric health and is often a measure of 
overall well-being, poor growth, evidenced by a decrease in previously attained weight 
and/or a negatively altered pattern of weight gain, is often associated with poor health, 
chronic illness, and acute or chronic malnutrition. The first year of life is the time of the 
most rapid ex utero growth. In infancy, lack of adequate energy, protein, and other 
nutrient intake will likely result in adverse effects on growth and has potential to affect 
neurodevelopmental maturation and behavior.24,28,29 Numerous studies have linked 
poor growth in infancy with diminished intellectual ability, lower than average 
Intelligence Quotient (IQ) and negative cognitive and behavioral outcomes in childhood 
and adolescence.29-32  
The typically developing infant gains between 20 to 30 grams per day in the first 
6 months of life following an expected physiologic weight loss that may reach and can 
exceed 10% of birth weight; in months 6 thru 12, weight gain slows to between 10 to 20 
grams per day.13,33,34 Adequate nutrient intake in infancy is crucial to promote a positive 
energy balance to support best potential for brain growth, neurologic development, and 
physical maturation. In the second year of life, physical development changes and 
weight gain further slows down to approximately 8 grams per day, while brain growth, 
estimated by head circumference measurement is expected to increase an average of 
0.33 centimeters (cm) per week and continue development late into childhood.24,35  
Incremental gains in crown-to-heel length average 0.66 cm per week in the first 6 
months of life, slowing to approximately 1.2 cm per month between 6 and 12 months of 
age.13,24 Many neonates with CHD do not meet these parameters despite being born 
 5 
 
full term and within the normal weight range for age and gender at birth.36,37 The 
inability to attain and maintain growth parameters within an acceptable range for age 
and gender, and/or a significant decrease from an established pattern of growth are 
indicators of growth failure and if not corrected can lead to associated physical and 
neurodevelopmental consequences.23,28-32,38  
The definition of growth failure in the pediatric medical and/or nursing literature 
is ambiguous and lacks a uniformly accepted approach to identify those infants at risk 
for and who exhibit poor growth. In general, growth failure, most often called failure to 
thrive (FTT), is defined as a disruption of the expected rate of growth, and can be the 
prelude to significant morbidity and mortality.39 The most common description of FTT is 
weight-for-age at or below the third to fifth percentile on more than one consecutive 
weight-for-age assessment, or weight-for-age measurements that descend two or more 
percentiles on a standard growth chart for age and gender.39-41 The definition of FTT 
can also be specific to the infant, by describing weight gain that negatively deviates 
from an established pattern of growth.41 Terms such as FTT, growth deficiency, growth 
failure, growth faltering, poor growth, protein energy malnutrition, and under-nutrition, 
are used interchangeably to describe less-than-adequate weight gain and poor 
physical development seen in infancy and early childhood.13,41-44 
Consequences of Growth Failure 
 Researchers have investigated prolonged, inadequate growth in early infancy 
and its effect on cognitive and neurodevelopmental maturation. Bhoomika and  
colleagues30 found growth failure, the result of poor nutrition, to be associated with 
cognitive impairments, decreased acquisition of intellectual processes and poor 
development of executive functions, including visual-spatial skills, working memory and 
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attention span. Dykman et al31 related deficits in growth measurements to deficiencies 
in cognitive development, poor school achievement and adverse behavior in school-
aged children.  In a population study of over 1,800 infants, McDougall and colleagues29 
found growth failure in the first two months of life to be a risk factor for decreased 
intellectual ability, lower IQ and developmental delay. Black et al45 reported cognitive 
deficiencies inclusive of poor work habits, deficient math skills and behavioral problems 
in 130 children with a known diagnosis of growth failure. These researchers also 
describe attenuation of the cognitive and neurobehavioral impairments they observed 
with early sustained intervention for both the child with growth failure and the primary 
parental caregiver.45 Collectively these studies provide evidence of a strong association 
between inadequate nutrient intake in early infancy and growth failure that have 
implications for negative cognitive, neurodevelopmental and behavioral outcomes in 
childhood. 
 Growth Failure in CHD 
For the infant with CHD who has undergone neonatal surgery, poor growth is a 
common co-morbidity that may have multiple factors contributing to its etiology. Factors 
presumed to affect weight change and contribute to poor growth in these infants can 
singularly or in combination include hemodynamic abnormalities related to cardiac 
physiology and disease severity,13,32,46 inadequate nutrient intake,1,5,45 gastrointestinal 
malabsorption,12,47-50 neurologic insults,12,36,47,51 and presumed increase in energy 
expenditure.11,33,52-55 Additionally, these infants may have fluid losses as high as 10% to  
15% compared to healthy infants, losses that can be attributed to tachypnea, poor fluid 
intake, and the necessary use of diuretics for fluid regulation related to the underlying 
cardiac disease.13,14,36,56 The dynamics of these factors and the impact they can have 
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pre- and/or postsurgical intervention may contribute to the growth failure often 
exhibited by these infants. Figure 1 conceptualizes potential influencing factors on 
growth for infants with CHD who have undergone neonatal surgery. 
The relationship between growth failure and cardiac physiology has long been a 
topic of discussion and investigation. The literature is robust with studies demonstrating 
that infants with cyanotic lesions and postoperative single-ventricle (SV) physiology 
exhibit more significant growth failure than infants with acyanotic disease or those with 
two normally functioning ventricles.14,15,17,48,57-60 The degree of growth failure has been 
associated with severity of hemodynamic impairment and/or the presence of heart 
failure.13,60 A right-to-left or left-to-right shunt between either the atria or the ventricles 
affects the infant’s hemodynamics and presumably has a negative effect on weight 
gain contributing to growth failure in this population. Cyanotic defects, such as 
Tetralogy of Fallot, Tricuspid Atresia and Hypoplastic Left Heart Syndrome are 
associated with right-to-left shunting of blood flow at the ventricular level, resulting in 
hypoxemia, often causing disturbances in both weight gain and attainment of 
stature.13,60,61 Alternatively, acyanotic lesions, Aortic Stenosis, Coarctation of the Aorta 
and Ventricular Septal Defect that manifest left-to-right shunting of blood at the atrial or 
ventricular level affects weight rather than stature in the pre-operative stage of 
disease.14,62 Regardless of the cardiac anatomy, growth failure for neonates and infants 
with CHD is a significant challenge and warrants further investigation to identify causal 
factors that if corrected may decrease morbidity and improve health outcomes.  
In addition to growth measures of weight, length and head circumference, there 
is high interest among healthcare providers and families in the behavioral, 
neurodevelopmental and cognitive outcomes following surgical intervention for CHD. 
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An association has been established between growth failure and increased infant 
irritability.63 Previous work from the parent study of this dissertation, reported infants 
with CHD, particularly those with postoperative SV physiology were more likely to 
exhibit growth failure, and have an increased level of irritability and negative 
behaviors.64  Limperopoulos et al27 reported a combination of preoperative, 
perioperative and postoperative factors influenced neurodevelopmental outcomes they 
observed in infants 12 to 18 months after neonatal surgery for CHD. These 
researchers found infant weight to be a significant predictor of motor and cognitive 
deficits at 2 years of age.27 The Boston Circulatory Arrest Trial, a large longitudinal 
study evaluated the neurodevelopmental status of participants at one, four and eight 
years of age following infant surgery for CHD in which the participants were 
randomized to either cardiac arrest or low-flow cardiopulmonary bypass for 
intraoperative organ support.37,65-67 Study findings demonstrated moderate neurologic 
deficits in motor coordination, and visual-motor integration, with mild deficits in speech 
and language, thought to be associated with the use of cardiac arrest versus the low 
flow cardiopulmonary bypass option during infant surgery.35,64-66 In a review of eight 
studies, Snookes and colleagues68 reported consistent delay in cognitive and motor 
development following surgery for CHD in early infancy.  In an extensive review of the 
literature reflecting progressive changes in cardiac surgery conducted by Shillingford 
and Wernovsky23 a number of consistent themes regarding neurologic outcomes for 
children with CHD who had undergone surgery in infancy were discovered. The  
authors cite common themes of: 1) prevalence of attention deficits and behavior 
problems; 2) deficits in visual-motor integration, visual-spatial challenges, and 
abnormalities in speech and language development; 3) impaired development of 
 9 
 
executive functioning; and 4) an association between intraoperative use of hypothermic 
cardiac arrest and/or cardiopulmonary bypass with neurodevelopmental abnormalities 
as sequela of surgery during infancy for cardiac disease.23 Predictors of these post 
surgical deficits may or may not include the primary underlying cardiac defect, the 
surgical approach, the decision for repair versus palliation, use of, type and duration of 
intraoperative organ support, and/or the existence of an unknown pre-surgical 
neurologic or genetic abnormality.25,38,68-71 Collectively, the evidence points to the need 
for close, repeated assessment of growth measures and incremental 
neurodevelopmental testing in infants and young children following surgical 
intervention for CHD to promote early identification of neurodevelopmental problems 
that may be minimized with prompt intervention(s).  
Other factors that potentially influence weight gain and growth in infants with 
CHD following neonatal surgery include metabolic rate and energy balance. A positive 
energy balance, the direct result of energy intake that exceeds energy utilization, is 
necessary to support somatic growth, neurobehavioral development, and long-term 
health.72-74 The utilization of energy is divided between that required for basal metabolic 
functions, thermal effects of digestion, requirements for tissue accretion, weight gain, 
and the cost of physical activity.73  In general, neonates have a higher metabolic rate 
compared to older children and adults, they require more kcal/kg of body weight.24,75 It 
is postulated that infants with CHD, particularly those with heart failure, require an 
increased energy intake to attain and maintain growth measurements within an  
 
acceptable range for age and gender. This increased requirement is thought to be from  
an increased oxygen consumption and inadequate caloric intake related to poor 
feeding ability, gut dysmotility, and/or gastrointestinal malabsorption.14,76 Infants with 
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heart failure may be in a fixed hypermetabolic state prior to and/or immediately 
following surgery, secondary to an increase in cardiopulmonary work and postoperative 
stress.52,60 This hypermetabolic state, whether or not it is fixed, may affect the infants’ 
energy intake and energy utilization. Growth failure often seen in infants with CHD 
following surgery may be the result of an imbalance between energy intake and energy 
utilization, however, available data do not consistently support this 
hypothesis.10,14,17,48,55,60 To date, studies suggesting an association between increased 
energy expenditure and poor growth in infants and children with complex CHD have 
yielded mixed results and are inconclusive due to study design, sample size, and a 
heterogeneous participant group.52,61,73,77,78  
Research endeavors specifically directed at examining energy intake and 
utilization by neonates and infants with CHD prior to, immediately following, and at an 
extended postsurgical time may elucidate the role energy balance and alterations in 
have on weight gain and the subsequent growth of infants with CHD.  With the known 
association between growth failure and poor neurodevelopmental and cognitive 
outcomes, it is essential to improve knowledge and understanding of factors 
contributing to poor growth in this population. This will better prepare healthcare 
providers to identify signs of growth failure, develop strategies toward decreasing the 
incidence of poor growth in infants with CHD, and increase their ability to achieve 
maximal growth, neurodevelopmental and intellectual potential. 
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Methods 
Parent Study: “Feeding Behaviors and Energy Balance in Infants with Congenital Heart 
Disease” 
The current body of work stems from a large, prospective study entitled: 
“Feeding Behaviors and Energy Balance in Infants with Congenital Heart Disease” 
(NIH/NINR R01 NR002093; MO1-RR00240; UL1-RR-024134), Principal Investigator: 
Barbara Medoff-Cooper, PhD, RN, FAAN, heretofore known as the “parent study.” 
Study approval was obtained from both Institutional Review Boards of The Children’s 
Hospital of Philadelphia (CHOP) and the University of Pennsylvania, Philadelphia.  
Study Design 
The parent study design was a prospective, longitudinal design, from a single 
center convenience sample.  
Study Setting  
The parent study is a single-institution investigation conducted at CHOP, a 430-
bed tertiary care facility serving the metropolitan Philadelphia area. During the study 
period, March 2003 through May 2007, more than 1,100 neonates were admitted to the 
Cardiac Intensive Care Unit (CICU) for evaluation of cardiac disease. The CICU staff 
consists of surgeons, physicians, nurses, respiratory therapists and ancillary staff 
specially trained in the intervention and therapeutic care of infants and children with 
congenital and acquired cardiac disease.  
Sample Population 
Infants were screened following surgery and if eligible parents/guardians were 
approached for enrollment. During the study period, 667 neonates in the CICU met 
criteria; of these, 502 families were approached with 164 enrolled, a 33% consent rate.  
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The low rate of consent is multi-factorial and reflects challenges faced in this research 
effort. These included absence of parent or guardian for consent, parental refusal to 
participate, parental perceived study burden and inability or unwillingness to return to 
CHOP for study visits. Additionally there were simultaneous ongoing studies in the 
CICU competing for enrollment of the same group of infants. Many infants who met 
criteria were from referral institutions where they would return for continued care and 
thus be unavailable for study visits. Demographic characteristics of infants with CHD 
who were not enrolled were similar to the enrolled group for gender, age, race, 
ethnicity and post-operative physiology (Table 2). Healthy infants that served as the 
control group were recruited from primary care practices affiliated with CHOP and self-
referral from surrounding communities. Demographic information on healthy infants not 
enrolled was not available. Total enrollment in the parent study was 242 combined 
cardiac and healthy infants. Race and ethnicity of the infants was assigned by parental 
self-identification. Families unwilling or unable to return to CHOP for study visits were 
not enrolled.  
Eligibility criteria for all infants included >36 weeks post-menstrual age and birth 
weight >2,500 grams.  Infants with CHD who underwent surgical intervention during the 
first 6 weeks of life, and did not have known multiple congenital, facial, chromosomal 
and/or complex gastrointestinal anomalies or congenital and/or acquired neurologic 
diagnoses were eligible for enrollment. Postoperative classification as SV or BV 
physiology was completed in keeping with established standards.79   
Data Acquisition 
 The study protocol commenced following hospital discharge when the infant 
was 3-months of age. All data was obtained during study visits in the outpatient Clinical  
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and Translational Research Center and the Nutrition and Growth Lab at CHOP, by 
trained research staff.  The study protocol did not include assessment of type, amount, 
or caloric density of daily nutrient intake or the rate of feeding advancement, the only 
distinction referred to oral and device or device-assisted feedings.  Dietary recall 
diaries were provided to families as part of the study protocol, with instruction to record 
nutrient intake for 3-days prior to or immediately following each study visit. The 
research staff phoned families bi-monthly to inquire on the infant’s status and to 
maintain interest in study participation. 
Purpose and Specific Aims 
The aim of the parent study was to develop a model to predict poor growth in 
postsurgical infants with CHD through a over the first year of life. Sub-analyses of data 
from the parent investigation has culminated in two studies that focus on examination 
of factors related to growth and growth failure in infants with CHD who underwent 
surgery in the first six weeks of life. These studies are presented in chapter two. The 
first is a descriptive examination of the pattern of growth velocity over the first year of 
life. This is a novel approach to describing growth as the study uses the new  World 
Health Organization (WHO) child growth velocity standards.80 The aim of this study 
was to examine the pattern of growth velocity, inclusive of weight, length, and head 
circumference for infants with CHD physiology compared to healthy controls. Growth 
velocity, defined as the change in measure over time, is considered a superior 
assessment of growth and more accurate than attained measures.80  Assessment of 
growth velocity allows early detection of poor growth which can indicate alterations in 
health and well-being or inadequate nutrient intake thereby facilitating early 
identification of infants at risk for growth failure.80,81  
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The second study in chapter two examines resting energy expenditure (REE) in 
infants with CHD compared to healthy infants at 3-months of age. There were two aims 
to this study, 1) to examine differences in REE between infants with CHD compared to 
healthy infants at 3 months of age and 2) to investigate if differences exist among 
infants with CHD having SV versus BV physiology.  This study uses WHO82 child 
growth standards for weight, length and head circumference for children from birth to 5 
years of age. These standards represent the best physiologic description of growth for 
infants and children living in ideal environments.73,80,82  
In chapter three, a grant application was developed and submitted for 
consideration of an Early Independent Investigator award in response to a call from the 
National Institutes of Health for educational-institution sponsored candidates. This 
proposal embraces a modified approach to the principle of translational research. 
Applying knowledge and skills gained through the course of this dissertation work in 
the measurement and analysis of energy expenditure the goal of this proposal was to 
identify differences between measured energy expenditure and the use of prediction 
equations to prescribe caloric intake for children with acute lung injury requiring 
mechanical ventilation. Using indirect calorimetry to measure energy expenditure will 
allow tailored prescriptions for energy intake for critically ill children, in whom good 
nutrition has a vital role in the process of recovery. Outcome measures for this 
proposal include: 1) increased number of ventilator-free days, 2) decreased weight 
loss, 3) decreased loss of lean body mass and 4) decreased length of stay.  Table 2 
describes the subject for each manuscript, and the grant proposal with the related 
specific aim.  
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Conclusion 
Multiple factors have an influence on growth in infants with CHD following 
neonatal surgery. Postsurgical physiology, severity of illness, feeding ability, neurologic 
status, and energy expenditure may all contribute to growth failure that many of these 
infants exhibit. The overall aim of this body of work is to explore the pattern of weight 
change and investigate factors that contribute to or influence growth or growth failure in 
the postsurgical infant with CHD. Monitoring growth velocity and understanding energy 
needs and the relationship they share with adequate growth will enable first-line care 
providers to better assess and intervene if growth failure is evident. Early recognition 
and intervention of growth failure can potentially improve patient outcomes and overall 
health. This work aims to initiate thoughtful collaboration among healthcare providers 
to address the challenge(s) of growth failure in neonates and infants with CHD who 
have undergone surgical intervention early in infancy.  
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Table 1 Definition of Terms 
 
Term 
 
Definition 
 
 
Acyanotic 
 
Absence of cyanosis; oxygenated blood in 
systemic circulations 
 
Bi-ventricle (BV) 
 
Normal two ventricle cardiac physiology; right 
ventricle receives blood from the systemic 
circulation pumps to the pulmonary circulation; 
left ventricle receives blood from the pulmonary 
circulation pumps to the systemic circulation 
 
Congenital Heart Disease (CHD) Anatomic or physiologic abnormality of the 
heart occurring in utero 
 
Congestive Heart Failure (CHF) The heart cannot deliver adequate cardiac 
output to meet the metabolic demands of the 
body  
 
Cyanotic  Deoxygenated blood in the systemic 
circulation; pale or blue discoloration to skin, 
face, hands, mucous membranes; related to 
type of cardiac defect and resulting physiology   
 
Growth Failure Weight attainment or weight change velocity is 
significantly below that of other infants of same 
sex and age, based on a prescribed reference 
standard 
 
Infant Child  from 1 month to 12 months of age 
 
Neonate Newborn infant from birth to 30 days of life  
 
Postsurgical physiology Functional and anatomic physiology of blood 
flow following surgical intervention for 
congenital heart disease 
 
Single Ventricle (SV) Cardiac defect with one functioning ventricle for  
pulmonary and systemic blood flow 
 
Weight Attainment Weight measured at a point in time; may be 
assessed as kilogram or z-score 
 
Weight Change Velocity Weight measured over specified time 
increments; may be assessed as kilograms, z-
score, or percentiles over time 
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Table 1 Comparison of infants with Congenital Heart Disease enrolled versus not 
enrolled.* 
 
 
Characteristics 
 
Total Enrolled   
% of n = 242 
 
         Not Enrolled   
          % of n = 338 
Gender 
      Male 
      Female 
 
61 
39 
 
76 
57 
 
Post Operative Physiologya 
      SV 
      BV 
 
 
33 
33 
 
 
22 
18 
 
 
Healthy Controlsb 
 
33 
 
- 
 
Racec 
      African-American    
      Asian 
      Caucasian 
      More than 1 Race 
      Unknown/No Response 
 
18 
  1 
69 
  6 
  6 
 
 
   9 
                 <1 
 54 
- 
   8 
 
 
Ethnicityc 
      Non-Hispanic 
      Hispanic 
      Unknown/No Response 
 
64 
  7 
29 
 
 
40 
  5 
  4 
 
 *Rounded % of total for each characteristic;  
 aPhysiology data for not enrolled subjects not confirmed  
 bComparable information on the unrecruited healthy infants was not available 
 cData for race and ethnicity in the not enrolled participants is incomplete; race and ethnicity is   
  assigned based on parent self-identification after enrollment  
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Table 2 Manuscripts and Specific Aims 
 
 
Chapter  
 
Specific Aim 
 
Chapter 2 
 
 
Section 1 
Growth Velocity over the First Year of Life 
Following Neonatal Surgery for Complex 
Congenital Heart Disease 
 
 
 
 
Section 2 
Resting Energy Expenditure at 3 Months of 
Age in Infants with Complex Congenital 
Heart Disease Following Neonatal Surgery  
 
 
To examine the pattern of growth 
velocity of weight, length, and head 
circumference for infants with 
postsurgical classification as SV 
physiology compared to healthy age-
matched controls over the first year of 
life. 
 
To investigate differences in energy 
expenditure between infants with CHD 
who have a postoperative classification 
as single-ventricle or two-ventricle 
physiology as compared to healthy 
age-matched controls at 3 months of 
age. 
 
Chapter 3 
 
 
 
The Use of Indirect Calorimetry (IC) to 
Measure Energy Needs in Mechanically 
Ventilated Children with Acute Lung Injury 
 
Use of IC derived measurements of - 
energy expenditure to prescribe 
nutrient intake specific to energy needs 
in critically ill, mechanically ventilated 
pediatric patients to increase 
ventilation-free days, decrease hospital 
stay, and improve overall outcome 
following critical illness in a specific 
patient population. 
 
Description of manuscripts of the dissertation 
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Figure 1 Conceptual Model of Potential Influences on Growth in CHD 
 
 
Infant 
with complex 
CHD
Influencing 
Factors
Cardiac  hemodynamic factors
Nutrient intake
Malabsorption 
Neurologic factors 
Surgical factors
Postoperative Course / Severity of Illness
Severity of Disease Growth
Weight Change Velocity
Weight for age z-score
Length for age z-score
HC for age z-score
Energy Balance
Potentially 
Modifiable 
Factor
Potential  Influences on Growth
 
Conceptualization of the potential components and processes having an effect on growth in 
infants following neonatal surgical intervention for CHD 
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CHAPTER 2 
Part 1 
Growth Velocity over the First Year of Life Following Neonatal Surgery for  
Congenital Heart Disease 
Abstract 
Background: Growth failure is well documented in infants with CHD. Poor growth in 
infancy has an effect on cognitive and neurobehavioral development. Assessment of 
growth velocity will identify infants at risk for growth failure.   
Objective: To assess growth using World Health Organization (WHO) growth velocity 
standards.   
Study Design: A descriptive, a sub-analysis from a prospective, longitudinal study in a 
large, metropolitan, cardiac center.  
Methods: Infants with CHD were recruited following surgery. Healthy infants were from 
primary practices and surrounding community. Growth measures were every 3 months. 
WHO velocity z-scores were calculated. Student’s t-test was used to assess 
differences between the groups.   
Results:  A total of 120 infants were included, 69 with CHD, 45% had SV physiology 
and 55% with BV. There were 65% males, and 80% were Caucasian. Males and 
females had statistically significant lower weight velocity z-score (males and females 
p<0.001) for the birth to 3-month interval. In subsequent intervals there was no 
difference in weight. Head circumference were different in velocity z-score only at the 
birth to 3-month interval for males (males p<0.001; females (p<0.05). Other velocity z-
scores were not different.  
Conclusion:
 
  Infants with CHD demonstrate poor growth velocity early in infancy. There 
was no difference in growth velocity after the birth to 3-month interval. WHO growth 
velocity standards are useful and may be more appropriate to assess growth patterns 
for infants with CHD.  
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Definition of Terms  
 
 
Term      
 
Definition 
 
Bi-Ventricle (BV) 
 
Normal two-ventricle cardiac physiology 
 
Congenital Heart Disease (CHD) 
 
Anatomic and/or physiologic abnormality 
of the heart occurring in utero, present at  
birth 
 
Growth Failure Weight attainment or weight change 
velocity that is significantly below 
reference standards for age and gender 
 
Growth Velocity Weight, length, head circumference 
measured over time; assessed as 
centimeters, grams, kilograms, or z-
score 
 
Infant Child from 30 days to end of 12 month 
 
Neonate Newborn child from birth to 30 days of 
life 
 
Postsurgical physiology Functional and anatomical physiology of 
blood flow following surgical intervention 
for congenital heart disease 
 
Single Ventricle (SV) Cardiac defect with one functioning 
ventricle for pulmonary and systemic 
blood flow 
 
Weight Attainment Weight measured at a point in time; 
assessed as centimeters, grams, 
kilograms 
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Growth Velocity over the First Year of Life Following Neonatal Surgery for  
Congenital Heart Disease 
Introduction 
Growth is often a gauge of an infant’s health, well-being and ability to thrive; it is 
fundamental to pediatric healthcare. In the US, current American Academy of 
Pediatrics guidelines recommend growth measurements at specified intervals to 
monitor an infant’s growth progress.1,2 The first year of life is a period of rapid growth, 
adequate nutrient intake is necessary to ensure acceptable weight gain, appropriate 
increase in stature and support best potential for brain development.  Alterations in 
growth that occur during the first year and cause the infant to fall below reference 
standards, may indicate growth failure and can have long-reaching consequences for 
neurobehavioral development, cognitive function and school performance.3-6 Infants 
with congenital heart disease (CHD), who have undergone surgery in the neonatal 
period, often fall short of growth measurements that meet gender- and age-specific 
reference standards, putting them at risk for consequences of the poor 
neurodevelopment that can result from growth failure in early infancy.7-10  
In 2006, the World Health Organization (WHO) introduced international child 
growth standards consisting of z-scores and percentile curves for male and female 
children aged 0 to 5 years.11 These standards describe how children should grow 
versus a depiction of attained growth at a point in time. Experts agree that the WHO 
standards represent the best physiologic growth for children under optimal 
environmental conditions, with adequate nutrition, free of psychological, socio-
economic and ethnicity biases.11 As an adjunct to the growth standards, WHO 
researchers developed growth velocity standards, introduced in 2009.12 Growth velocity 
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defined as the change in measure over time, accounts for the normal individual pattern 
of variability characteristic of saltatory, catch-up or slow-down growth.12  Growth 
velocity can be highly variable, despite this it is considered a superior assessment and 
may prove to be more appropriate than attained growth values. It allows for early 
detection of infants and children at risk of falling below reference growth trajectories.  
To better understand growth and growth patterns of infants with CHD following 
surgery in the neonatal period, we examined growth velocity using the WHO 
standards.12 The aim of this study is to describe the velocity of growth for weight, 
length, and head circumference over the first year of life in 3-month intervals for infants 
with CHD following neonatal surgery as compared to healthy infants of similar age and 
gender.  Table 1 is a definition of terms and abbreviations. 
Study Design and Setting 
 This is a descriptive sub-analysis from a convenience sample of a prospective, 
longitudinal study conducted at The Children’s Hospital of Philadelphia (CHOP), 
between March 2003 and May 2007.  Study approval was obtained from the CHOP 
Institutional Review Board, and informed consent was obtained prior to 
commencement of study procedures. 
Study Sample 
 Neonates were recruited from the Cardiac Intensive Care Unit at CHOP. 
Healthy infants from primary care practices affiliated with CHOP and the community at 
large served as the control group. Eligible participants were 36 weeks post-menstrual 
age with birth weight of > 2,500 grams. Birth data were extracted from records that 
accompanied the infant to CHOP or by parental report for healthy infants. Infants with 
known or overt chromosomal abnormalities, multiple congenital and/or facial 
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anomalies, or complex gastrointestinal or congenital and/or acquired neurologic insults 
were not eligible as these factors are associated with poor growth. Infants with CHD 
were classified as single ventricle (SV) or biventricular (BV) physiology in the usual 
manner.13 Race and ethnicity were assigned based on parent self-identification.  
Study Methods 
All study visits were conducted at CHOP in the Clinical and Translational 
Research Center and the Nutrition and Growth Lab. Study measurements were 
obtained by research personnel using standard protocol.14 Design of the larger study 
included study visits in 3-month intervals beginning at 3-months of age through 12 
months. Goal timing of study visits was set within 2 weeks before or after the infant’s 
birth date.  Infants who attended a minimum of two of five study visits, one being the 3-
month visit and had birth weight data were included in this analysis. 
Weight was measured in kilograms (kg) using a Scale-Tronix (Scale-Tronix, 
White Plains, NY, USA) infant pan scale, accurate to 5 gm.  Recumbent length 
measured in centimeters (cm) was obtained using an infant length board (Holtain 
Limited, Crymuch, UK) accurate to 0.1 cm.  Head circumference was measured using 
a non-stretchable tape and measured to 0.1 cm (McCOY Health Science Supply, 
Maryland Heights, MO, USA).  Measurements were obtained in triplicate, and the 
calculated mean used for analysis. Using WHO standards,11,15 measures of weight, 
length, and head circumference were converted to z scores. Calculations for weight 
growth velocity were calculated in four, 3-month intervals. Velocities for length and 
head circumference were calculated for three intervals owing to incomplete birth data 
for these measures. 
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Statistical Analysis 
 All analyses were completed using the SAS V9.2 (SAS Institute, Cary, NC) 
statistical analysis program. Statistical significance was determined at the p<0.05 level.  
Descriptive statistics of the means, standard deviations, medians, and minimum and 
maximum values for each measure were calculated. Distribution plots were used to 
assess normality of the data.  
 Velocity for each growth parameter for each infant for each time interval was 
calculated using the equation:  
unit of measure/day = Δ in growth parameter ÷ length of interval in days, 
where the change (Δ) in growth parameter is the difference between the measured 
weight, length or head circumference obtained at two contiguous study visits. That 
change was then divided by the time interval in days between study visits. The result is 
the unit of measure/day.  An example of calculation for weight velocity is: 
        20.8 gm/day = 5800 gm – 3550 gm ÷ 108 days,   
where 5800 gm is the 3-month visit weight, 3550 gm is the birth weight, 108 days is the 
number of days between birth and the 3-month study visit, resulting in 20.8 gm/day 
weight change over 108 days. 
 The next step was to correct the velocity to the specified 3-month interval of the 
study protocol. This was done by multiplying the derived unit of measure by 91.2 to 
account for months with 30 and 31 days. The result is a value representing the change 
specific to a 3-month interval. Using the example above: 
 1897 gm over 3 months (total weight change) = 20.8 gm/day x 91.2 days.   
The same procedures were repeated to calculate the velocity of length and head 
circumference for each infant for each time interval.   
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 Velocity z-score for each growth parameter was then calculated using the WHO 
equations12 based on 3-month intervals, 0 – 3, 3 – 6, 6 – 9, and 9 – 12, as specified in 
the larger study protocol. To enable comparison of the groups, z-scores were 
calculated using the lambda (L), mean (M), standard deviation (S), and delta values 
specified in the WHO procedure for the 3-month intervals indicated.12 The WHO 
velocity z-score was calculated using the equation: 
  12, 
where  represents the growth parameter increment (weight, length or head 
circumference) for t, the visit age interval; LMS values are from the WHO tables for 3-
month intervals by gender. Once velocity z-scores were calculated for all parameters, 
two-sided Student’s t-test was used to compare differences at each interval between 
healthy infants to infants with CHD by gender.  
Results 
 There were 130 infants who met inclusion criteria. Three infants with CHD died 
prior to study completion due to complications of their cardiac disease. Five healthy 
infants did not have birth weight data and two families withdrew from study 
participation. There were 120 infants included at the initiation of this analysis. Of these, 
69 were infants with CHD, 31 (45%) with SV physiology, 38 (55%) with BV physiology; 
51 were healthy infants. The distribution of diagnoses for infants with CHD is presented 
in Table 2. Data are presented by gender with healthy infants compared to infants with 
CHD, as small sample size did not permit examination of the data in infants with CHD 
by physiology. The number of participants at each visit, for each measure and each 
interval was determined. Study sample demographics are presented in Table 3.  The 
data are grouped and presented by growth parameter, illustrating the group mean, 
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WHO z-score, parameter measurement change over time and WHO velocity z-score 
(Tables 4, 5, 6, and 7). 
 Birth weight in grams and z-score were not different among the groups. The 
mean attained weight was significantly less for males with CHD compared to healthy 
males (5517 gm, z-score -1.4, p<0.001) at 3-months, with a statistically significant 
decreased weight change in the birth to 3 month interval (2015 gm, p<0.001). The 
weight velocity z-score further demonstrated this decreased weight change, z-score 
 -1.82, p<0.001 compared to healthy males. This trend of decreased mean attained 
weight continued and remained negative and statistically significant in males for each 
time point (Table 6). There was a 20% drop in attendance from the 3-month to 6-month 
visit and a 22% drop from the 6-month to 9-month visit.  At 12 months, males with CHD 
had 89% attendance, a 40% increase from the 9- month visit. The attained weight at 12 
months although still significantly less than healthy in males (9398 gm, p=0.04) showed 
improvement. There was no difference in weight change or weight velocity z-score 
after the birth to 3-month interval.  
 Females with CHD demonstrated a statistically significant decrease in attained 
weight (5422 gm, p=0.02) at the 3-month visit compared to healthy females. The birth 
to 3-month interval weight change (1764 gm) and weight z-score velocity (-1.8) were 
also significantly lower (p<0.001) than for healthy females. Attained weight, weight z-
score, weight change, and weight velocity z-score were not different between females 
with CHD and healthy females at any other time point or interval. Females with CHD 
represented the smallest number of participants at each study visit. Table 7 compares 
healthy females to females with CHD for each growth parameter.  
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Males with CHD demonstrated significantly lower attained length at each study 
visit compared to healthy males; the length z-score, length change and length velocity 
z-score were not different (Table 6).  Head circumference showed a similar pattern to 
weight in males with CHD compared to healthy males, with the exception of the 12-
month visit where attained head circumference was not different between the groups. 
The head circumference velocity z-score for males (0.1) was negatively significant at 
the birth to 3-month interval, p<0.01. No other intervals were different from those in 
healthy males.  
 Length for females with CHD was not different from healthy females at any visit 
or any time interval. The attained measure for head circumference in females with CHD 
was significantly lower (39 cm, p<0.05) than in healthy females at the 3-month visit, no 
difference was demonstrated in attained measurement, head circumference z-score, 
head circumference change or head circumference velocity z-score for any other time 
point or time interval. Females with CHD demonstrated a drop in attendance of 26% 
from the 3 to 6-month visit, 29% from the 6 to 9-month visit and an increase of 43% 
from the 9 to 12-month visit, which has a critical impact on the findings. In addition, 
there was more than 20% missing data for each measurement across the study 
critically affecting the findings and limiting the conclusions that can be derived.  
Discussion 
In this study, using the new WHO growth and growth velocity standards to 
evaluate infants with CHD compared to healthy infants of similar age and gender, we 
demonstrate decreased attained weight, decreased interval weight change and 
negative weight velocity z-scores in both males and females with CHD at 3-months of 
age. The small sample size and missing data necessitate cautious interpretation of 
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these findings. Despite this, these data give promise for better understanding of the 
pattern of growth in infants with CHD who have undergone neonatal surgery.  
 Infants are expected to gain between 20 and 30 grams/day in the first 6 
months of life following a physiologic weight loss in the first days of life up to and 
exceeding 10%.16-18 This rate of growth is different in exclusively breastfed infants.17 
From these data, it appears that on average infants with CHD are at the lower end of 
this expected range for weight gain or do not meet it, particularly in the first 3-months of 
life.  In our study, males with CHD showed a mean weight change in the birth to  
3- month interval of 2015 gm, approximately 22gm/day; the mean weight change in 
healthy males was approximately 29 gm/day. Using the WHO growth velocity 
standards, this change is equal to a weight velocity z-score of -1.82 and corresponds to 
the 3rd to 5th percentile of weight velocity for age and gender. In the same birth to 3-
month period, females with CHD demonstrated a weight change of 19 gm/day 
compared to 27 gm/day in healthy females; they too are in the 3rd to 5th percentile with 
a corresponding weight velocity z-score of -1.8. For the birth to 3-month interval, both 
females and males with CHD demonstrated growth velocity below the 5th percentile by 
WHO standards. Although these are the mean values of the respective groups, it is the 
low weight velocity z-scores in conjunction with low attained weight that are of concern. 
These values represent significant growth failure at this time interval, supporting the 
existing evidence that describes poor weight gain in infants with CHD in early infancy. 
The attained weight in males with CHD remained statistically significant and below that 
of healthy males throughout the study period. Following the birth to 3-month interval 
weight change and weight velocity z-scores were not different for males or females 
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with CHD compared to healthy infants of the same gender, suggesting catch-up growth 
occurs subsequent to 3-months of age.  
 Attained length for males with CHD was significantly below that of healthy 
males at each study visit (Table 6) however, the change in length and length velocity z-
score were not different, suggesting that although length at 3-months of age is lower 
than that in healthy infants, the rate of increase is the same. Length for female infants 
with CHD was not different from healthy females in our study sample. Several studies 
of infants with CHD report linear growth delay in early infancy, with catch up growth for 
length commencing later in infancy and progressing at a slower rate than weight catch 
up growth.10,19,20 These studies suggest that delayed attainment of length in infants with 
CHD following neonatal surgery is reversible.   
 Head circumference is the best determinant of brain growth.21,22 In males with 
CHD in our study sample, attained head circumference was decreased from that of 
healthy males with no difference by 12 months of age. Females with CHD 
demonstrated a negative statistically significant difference only at 3-months and only 
for the attained head circumference measurement (39 cm, p=0.01); this finding is likely 
skewed due to small sample size. Research suggests that prenatally, infants with CHD 
have smaller brain volume and decreased brain growth; this low volume presents at 
birth as small head circumference and may indicate global neurologic immaturity.21-23 
This decreased brain volume and the potential for slow brain growth can have a direct 
effect on neurodevelopment, cognition, and behavior in childhood.22,24 
 Monitoring growth parameters is an important component of care for infants and 
young children, particularly infants with CHD who have undergone neonatal surgery. 
Although limited, the data presented show significantly decreased growth in males and 
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females at 3-months of age with promise for catch up in late infancy. We used WHO 
standards for growth11 and growth velocity12 to evaluate these data as it is believed 
these standards provide a more precise assessment of how growth is occurring over 
time compared to how it has occurred at a point in time. Ross and colleagues25 
demonstrated a downshift or poor weight attainment in early infancy, at 2 to 4 months 
of age, and found to be predictive of later poor growth despite an interval period of 
growth recovery. These researchers suggest that healthcare providers use 
acceleration and deceleration standards to identify patterns of growth in infants at risk, 
initiate stringent monitoring procedures and provide early interventions for those infants 
whose pattern of growth in early infancy suggests growth failure.25 
 Poor growth in early infancy has been associated with infant irritability, cognitive 
impairments, delayed development of executive functions, developmental delay, poor 
school achievement, and deficits in motor, speech and language skills.4,5,26,27 In a 
population based study, Gale et al28 reported prenatal head growth and head growth 
during infancy to be particularly important determinants for subsequent intelligence, 
further, they found head growth after infancy did not appear to compensate for 
decreased growth during infancy.  McDougall et al4 studied over 1800 infants with 
documented poor growth in the first months of life and found an association to 
decreased intellectual ability and lower IQ at school age. These studies present 
evidence of an association between poor growth in infancy and negative impact on 
neurodevelopment and intelligence in childhood. 
The data presented here, demonstrate growth failure in the infants with CHD. 
Contributing factors that may have a role in poor growth evidenced in infants with CHD 
include inadequate energy intake to promote a positive energy balance,29-32 
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gastrointestinal tract abnormalities,33,34 neurologic immaturity,21,23,35 and feeding 
dysfunction.36-38 Regardless of the etiology, the potential short and long-term 
consequences of poor growth can be detrimental to the infant and are a focus of 
interest. Reviews of studies investigating neurobehavioral and neurodevelopmental 
outcomes following surgery for CHD have consistently found reports of delay in 
cognitive and motor development, attention deficits and altered development of speech 
and language skills.6,39-41 These documented consequences of growth failure and the 
impact they can exert on growth and long-term intellectual development are ample 
cause to further investigate contributors to poor growth in this population and seek 
viable interventions to minimize its occurrence.  
Study Limitations 
 Limitations include this being a convenience sample from a single center with 
high illness acuity of cardiac disease. There was a large amount of missing data 
resulting in small sample size. Dietary intake records were not available to assess 
energy intake simultaneously with growth in these infants. All birth data were parent 
report or extracted from the transfer record that accompanied the infants with CHD.  
Some bias may exist in that families who enrolled were motivated to participate in a 
complex study protocol. 
Conclusion 
 Poor growth is a common morbidity in infants with CHD who have undergone 
neonatal surgery. In this study, the use of the WHO growth and growth velocity 
standards presents a novel approach to examine growth in our cohort of infants with 
CHD.  We found a pattern of poor growth in the birth to 3-month interval across gender, 
a time usually associated with rapid growth and development. From these limited data, 
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growth in all measures appears to begin catch-up following the initial interval of poor 
growth. Further study with a larger sample is and fewer missing data points is 
necessary for a better evaluation of these findings. However, these data are important 
and may be the first to use the WHO growth velocity standards to evaluate growth in a 
cohort of chronically ill infants. Use of this methodology may assist providers in early 
identification of poor growth in infants with CHD following surgery in the neonatal 
period and facilitate  timely interventions to prevent or minimize growth failure, 
decreasing the risk for and potential of negative cognitive and neurodevelopmental 
sequelae associated with poor growth in early infancy, particularly in infants with CHD.   
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Table 2 CHD Primary diagnosis of infants with Congenital Heart Disease  
 
            Primary Diagnosis 
 
Postsurgical Physiology 
 
 
 
Single Ventricle 
% of N = 31 
 
Bi-Ventricle 
% of N = 38 
 
Hypoplastic Left Heart Syndrome 
 
59 
 
Tricuspid Atrestia 
 
16 
 
Double Inlet Left Ventricle 
 
  6 
 
L-Transposition of Great Arteries 
  
  3 
 
D-Transposition of Great Arteries 
 
  6 
 
47 
Double Outlet Right Ventricle 
 
  3 
 
 3 
Valvular Pulmonary Atresia 
 
  6 
 
 3 
Coarctation of the Aorta 
  
21 
Tetrology of Fallot 
  
11 
Interrupted Aortic Arch 
  
 5 
Truncus Arteriosus 
  
 2 
Aortopulmonary Window 
  
 2 
Valvular Aortic Stenosis 
  
 2 
 
Total Anomalous Pulmonary Venous 
Return 
 
  
 3 
  Distribution of diagnoses across sample of infants with CHD, with postsurgical cardiac    
  classification 
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Table 3 Study sample demographics 
 
 
Healthy Infants   
 
     Infants with Congenital Heart Disease 
 
   Single Ventricle 
 
Bi-Ventricle 
 
N 
 
51 
 
31 
 
38 
 
Gender  
    Female 
    Male 
 
 
19 
32 
 
 
  8 
23 
 
 
15 
23 
 
Race  
   AA 
   Asian 
  Caucasian 
   >1  
  Not Reported 
 
 
13 
  1 
33 
  2 
  2 
 
 
 4 
- 
26 
- 
1 
 
 
- 
- 
37 
1 
- 
 
Ethnicity 
    Hispanic 
    Non-Hispanic 
    Not Reported 
 
   
2 
42 
  6 
 
 
  2 
21 
  8 
 
 
 3 
25 
  9 
 
Gender, race, and ethnicity distribution of study sample. 
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Table 4 Mean (SD) growth parameters, healthy females and males  
 
Healthy Females 
 
Healthy Males 
 
Time  Birth 3 6 9 12 Birth 3 6 9 12 
n 19 19 19 17 19 32 32 32 24 27 
Age 
(d) 0 
98 
(15) 
194 
(18) 
270 
(11) 
374 
(17) 0 
93 
(9) 
191 
(15) 
276  
(14) 
370 
(17) 
 
Wta 
gm 
 
z-     
score 
 
Wt Δ, 
gmb 
 
Wt 
z-velc 
 
3304 
(0.5) 
 
0.1 
(1.1) 
 
 
 
5984      
(0.8) 
 
-0.1   
(1.0) 
 
2461 
(562) 
 
-0.3 
(1.1) 
 
7379        
(0.8) 
 
-0.1     
(0.9) 
 
1419 
(393) 
 
-0.2 
(1.0) 
 
8376     
(1.0) 
 
0.1 
(1.0) 
 
903 
(460) 
 
-0.2 
(1.3) 
 
9195    
(1.1) 
 
0.1 
(0.9) 
 
918 
(303) 
 
0.6 
(0.9) 
 
3576 
(0.6) 
 
0.4 
(1.1) 
 
 
 
6272 
(0.6) 
 
-0.2 
(0.8) 
 
2653 
(601) 
 
-0.6 
(1.1) 
 
7969 
(1.0) 
 
-0.1 
(1.0) 
 
1570 
(404) 
 
-0.1 
(1.0) 
 
9213 
(0.7) 
 
0.3 
(0.6) 
 
1194 
(546) 
 
0.5 
(1.7) 
 
9952 
(1.0) 
 
0.2 
(1.0) 
 
875 
(377) 
 
0.3 
(1.1) 
 
Lta 
cm 
 
z-
score 
 
Lt Δ, 
Gmb 
 
Lt  
 z-velc 
 
 
 
 
61 
(2.8) 
 
-0.31 
(1.3) 
 
 
 
 
66 
(2.1) 
 
-0.0 
(0.9) 
 
5.5 
(2.1) 
 
-0.5 
(2.0) 
 
70 
(2.3) 
 
0.3 
(1.3) 
 
-0.1 
(1.0) 
 
-0.3 
(1.6) 
 
73 
(1.2) 
 
-0.3 
(0.8) 
 
3.7 
(1.4) 
 
-0.2 
(1.5) 
  
62 
(2.4) 
 
0.3 
(1.1) 
 
69 
(2.8) 
 
-0.0 
(1.0) 
 
5.5 
(2.1) 
 
-0.2 
(1.1) 
 
73 
(3.0) 
 
0.6 
(1.3) 
 
4.6 
(1.5) 
 
0.3 
(1.5) 
 
77 
(3.0) 
 
0.3 
(1.2) 
 
3.4 
(1.3) 
 
-0.5 
(1.5) 
 
HCa 
cm 
 
z-
score 
 
HC Δ, 
Gmb 
 
HC  
z-velc 
 
 
 
 
40 
(1.4) 
 
0.5 
(1.0) 
 
 
 
43 
(1.1) 
 
0.5 
(0.8) 
 
2.7 
(0.5) 
 
-0.5 
(2.0) 
 
45 
(1.3) 
 
0.8 
(1.0) 
 
1.8 
(0.7) 
 
-0.3 
(1.6) 
 
45 
(1.0) 
 
0.4 
(0.7) 
 
0.7 
(1.3) 
 
-0.2 
(1.5) 
  
41 
(1.3) 
 
0.4 
(1.1) 
 
 
 
44 
(1.2) 
 
0.3 
(0.8) 
 
2.7 
(0.6) 
 
-0.2 
(1.1) 
 
46 
(1.1) 
 
0.5 
(1.0) 
 
1.7 
(0.6) 
 
0.3 
(1.5) 
 
47 
(1.3) 
 
0.5 
(1.0) 
 
1.2 
(0.5) 
 
-0.5 
(1.5) 
*Weight for birth data only; aParameter means (SD), bParameter interval Δ (SD), cParameter 
interval velocity z-score 
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Table 5 Mean (SD) growth parameters, females and males with CHD 
 
                       Females with CHD 
 
                Males with CHD 
 
Time  Birth 3 6 9 12 Birth 3 6 9 12 
n 23 23 17 12 21 46 46 37 29 41 
Age 
(d) 0 
99 
(16) 
192 
(17) 
272 
(12) 
375 
(17) 0 
96 
(13) 
  189 
(15) 
277 
(16) 
380 
(19) 
 
Wta 
gm 
 
z-
score 
 
Wt Δ, 
gmb 
 
Wt  
 z-
velc 
 
3491 
(0.5) 
 
0.0 
(1.0) 
 
 
 
5422§      
(0.7) 
 
-0.9 
(1.0) 
 
1764‡ 
(545) 
 
-1.8‡ 
(1.3) 
 
6982       
(0.9) 
 
-0.6 
(1.1) 
 
1524 
(246) 
 
0.1 
(0.7) 
 
8217 
(1.0) 
 
-0.1 
(1.0) 
 
1056 
(296) 
 
0.3 
(0.8) 
 
9119      
(1.1) 
 
0.0 
(1.0) 
 
901 
(424) 
 
0.5 
(1.2) 
 
3396 
(0.5) 
 
0.1 
(1.0) 
 
5517‡ 
(0.9) 
 
-1.4 
(1.2) 
 
2015‡ 
(606) 
 
-1.82‡ 
(1.2) 
 
7257¥ 
(1.0) 
 
-1.0 
(1.1) 
 
1607 
(347) 
 
0.0 
(1.0) 
 
8303‡ 
(1.1) 
 
-0.7 
(1.2) 
 
1080 
(493) 
 
0.2 
(1.4) 
 
9398§ 
(1.1) 
 
-0.4 
(1.1) 
 
833 
(506) 
 
0.2 
(1.5) 
 
Lta 
cm 
 
z-
score 
 
Lt Δ, 
gmb 
 
Lt  
 z-
velc 
 
 
 
 
60 
(2.5) 
 
-0.4 
(1.2) 
 
 
 
66 
(3.4) 
 
-0.6 
(1.4) 
 
6.5 
(1.3) 
 
0.5 
(1.2) 
 
71 
(2.8) 
 
0.3 
(1.2) 
 
4.8 
(1.5) 
 
0.4 
(1.5) 
 
74 
(3.0) 
 
0.0  
(1.1) 
 
3.8 
(1.2) 
 
-0.1 
(1.3) 
  
60‡ 
(2.8) 
 
-0.4 
(1.2) 
 
 
 
66¥ 
(2.5) 
 
-0.7 
(1.1) 
 
6.4 
(1.5) 
 
0.1 
(1.3) 
 
70‡ 
(2.9) 
 
-0.8 
(1.2) 
 
4.7 
(1.0) 
 
0.4 
(1.0) 
 
75§ 
(2.8) 
 
-0.6 
(1.2) 
 
3.3 
(2.0) 
 
-0.2 
(1.4) 
 
HCa 
cm 
 
z-
score 
 
HC 
Δ, 
gmb 
 
HC  
z-velc 
 
 
 
 
39§ 
(1.1) 
 
-0.34 
(1.1) 
 
 
 
 
43 
(1.0) 
 
-0.2 
(0.9) 
 
3.0 
(0.4) 
 
0.5 
(1.2) 
 
45 
(1.6) 
 
-0.4 
(1.3) 
 
1.6 
(1.0) 
 
0.4 
(1.5) 
 
46 
(1.6) 
 
0.0 
(1.2) 
 
1.3 
(0.7) 
 
-0.1 
(1.3) 
  
40‡ 
(1.7) 
 
-0.9 
(1.4) 
 
 
 
43§ 
(1.4) 
 
-0.3 
(1.1) 
 
3.3§ 
(0.7) 
 
0.1¥ 
(1.3) 
 
45§ 
(1.7) 
 
-0.3 
(1.4) 
 
1.7 
(1.0) 
 
0.4 
(1.0) 
 
46 
(1.6) 
 
-0.0 
(1.3) 
 
1.4 
(0.8) 
 
-0.2 
(1.4) 
 
*Weight for birth data only; aParameter means (SD), bParameter interval Δ (SD), cParameter 
interval velocity z-score; Student’s t-test significance levels §p<0.05, ¥p<0.01 ‡p<0.001 
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Table 6 Mean (SD) growth parameters, healthy males and males with CHD 
 
Healthy Males 
 
Males with CHD 
 
Time  Birth 3 6 9 12 Birth 3 6 9 12 
n 32 32 32 24 27 46 46 37 29 41 
Age 
(d) 0 
93 
(9) 
191 
(15) 
276  
(14) 
370 
(17) 0 
96  
(13) 
  189 
(15) 
277 
(16) 
380 
(19) 
 
Wta 
gm 
 
z-
score 
 
Wt Δ, 
gmb 
 
Wt  
 z-velc 
 
3576 
(0.6) 
 
0.4 
(1.1) 
 
 
 
6272 
(0.6) 
 
-0.2 
(0.8) 
 
2653 
(601) 
 
-0.6 
(1.1) 
 
7969 
(1.0) 
 
-0.1 
(1.0) 
 
1570 
(404) 
 
-0.1 
(1.0) 
 
9213 
(0.7) 
 
0.3 
(0.6) 
 
1194 
(546) 
 
0.5 
(1.7) 
 
9952 
(1.0) 
 
0.2 
(1.0) 
 
875 
(377) 
 
0.3 
(1.1) 
 
3396 
(0.5) 
 
0.1 
(1.0) 
 
5517‡ 
(0.9) 
 
-1.4 
(1.2) 
 
2015‡ 
(606) 
 
-1.82‡ 
(1.2) 
 
7257¥ 
(1.0) 
 
-1.0 
(1.1) 
 
1607 
(347) 
 
0.0 
(1.0) 
 
8303‡ 
(1.1) 
 
-0.7 
(1.2) 
 
1080 
(493) 
 
0.2 
(1.4) 
 
9398
§ 
(1.1) 
 
-0.4 
(1.1) 
 
833 
(506) 
 
0.2 
(1.5) 
 
Lta 
cm 
 
z-
score 
 
Lt Δ, 
gmb 
 
Lt  
 z-velc 
  
62 
(2.4) 
 
0.3 
(1.1) 
 
69 
(2.8) 
 
-0.0 
(1.0) 
 
5.5 
(2.1) 
 
-0.2 
(1.1) 
 
73 
(3.0) 
 
0.6 
(1.3) 
 
4.6 
(1.5) 
 
0.3 
(1.5) 
 
77 
(3.0) 
 
0.3 
(1.2) 
 
3.4 
(1.3) 
 
-0.5 
(1.5) 
  
60‡ 
(2.8) 
 
-0.4 
(1.2) 
 
 
 
66¥ 
(2.5) 
 
-0.7 
(1.1) 
 
6.4 
(1.5) 
 
0.1 
(1.3) 
 
70‡ 
(2.9) 
 
-0.8 
(1.2) 
 
4.7 
(1.0) 
 
0.4 
(1.0) 
 
75§ 
(2.8) 
 
-0.6 
(1.2) 
 
3.3 
(2.0) 
 
-0.2 
(1.4) 
 
HCa 
cm 
 
z-
score 
 
HC Δ, 
gmb 
 
HC  
z-velc 
  
41 
(1.3) 
 
0.4 
(1.1) 
 
 
 
44 
(1.2) 
 
0.3 
(0.8) 
 
2.7 
(0.6) 
 
-0.2 
(1.1) 
 
46 
(1.1) 
 
0.5 
(1.0) 
 
1.7 
(0.6) 
 
0.3 
(1.5) 
 
47 
(1.3) 
 
0.5 
(1.0) 
 
1.2 
(0.5) 
 
-0.5 
(1.5) 
  
40‡ 
(1.7) 
 
-0.9 
(1.4) 
 
 
 
43§ 
(1.4) 
 
-0.3 
(1.1) 
 
3.3§ 
(0.7) 
 
0.1¥ 
(1.3) 
 
45§ 
(1.7) 
 
-0.3 
(1.4) 
 
1.7 
(1.0) 
 
0.4 
(1.0) 
 
46 
(1.6) 
 
-0.0 
(1.3) 
 
1.4 
(0.8) 
 
-0.2 
(1.4) 
*Weight for birth data only; aParameter means (SD), bParameter interval Δ (SD), cParameter 
interval velocity z-score; Student’s t-test significance levels §p<0.05, ¥p<0.01 ‡p<0.001 
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Table 7 Mean (SD) growth parameters, healthy females and females with CHD 
 
Healthy Females 
 
Females with CHD 
 
Time Birth 3 6 9 12 Birth 3 6 9 12 
n 19 19 19 17 19 23 23 17 12 21 
Age 
(d) 
0 98 
(15) 
194 
(18) 
270 
(11) 
374 
(17) 
0 99  
(16) 
192 
(17) 
272 
(12) 
375 
(17) 
 
Wta 
gm 
 
z-     
score 
 
Wt Δ, 
gmb 
 
Wt 
z-velc 
 
3304 
(0.5) 
 
0.1 
(1.1) 
 
 
 
5984      
(0.8) 
 
-0.1   
(1.0) 
 
2461 
(562) 
 
-0.3 
(1.1) 
 
7379        
(0.8) 
 
-0.1     
(0.9) 
 
1419 
(393) 
 
-0.2 
(1.0) 
 
8376     
(1.0) 
 
0.1 
(1.0) 
 
903 
(460) 
 
-0.2 
(1.3) 
 
9195    
(1.1) 
 
0.1 
(0.9) 
 
918 
(303) 
 
0.6 
(0.9) 
 
3491 
(0.5) 
 
0.0 
(1.0) 
 
 
 
5422§      
(0.7) 
 
-0.9 
(1.0) 
 
1764‡ 
(545) 
 
-1.8‡ 
(1.3) 
 
6982       
(0.9) 
 
-0.6 
(1.1) 
 
1524 
(246) 
 
0.1 
(0.7) 
 
8217 
(1.0) 
 
-0.1 
(1.0) 
 
1056 
(296) 
 
0.3 
(0.8) 
 
9119      
(1.1) 
 
0.0 
(1.0) 
 
901 
(424) 
 
0.5 
(1.2) 
 
Lta 
cm 
 
z-
score 
 
Lt Δ, 
Gmb 
 
Lt 
z-velc 
 
 
 
 
61 
(2.8) 
 
-0.31 
(1.3) 
 
 
 
 
66 
(2.1) 
 
-0.0 
(0.9) 
 
5.5 
(2.1) 
 
-0.5 
(2.0) 
 
70 
(2.3) 
 
0.3 
(1.3) 
 
-0.1 
(1.0) 
 
-0.3 
(1.6) 
 
73 
(1.2) 
 
-0.3 
(0.8) 
 
3.7 
(1.4) 
 
-0.2 
(1.5) 
 
 
 
 
60 
(2.5) 
 
-0.4 
(1.2) 
 
 
 
66 
(3.4) 
 
-0.6 
(1.4) 
 
6.5 
(1.3) 
 
0.5 
(1.2) 
 
71 
(2.8) 
 
0.3 
(1.2) 
 
4.8 
(1.5) 
 
0.4 
(1.5) 
 
74 
(3.0) 
 
0.0  
(1.1) 
 
3.8 
(1.2) 
 
-0.1 
(1.3) 
 
HCa 
cm 
 
z-
score 
 
HC Δ, 
Gmb 
 
HC 
z-velc 
 
 
 
 
40 
(1.4) 
 
0.5 
(1.0) 
 
 
 
43 
(1.1) 
 
0.5 
(0.8) 
 
2.7 
(0.5) 
 
-0.5 
(2.0) 
 
45 
(1.3) 
 
0.8 
(1.0) 
 
1.8 
(0.7) 
 
-0.3 
(1.6) 
 
45 
(1.0) 
 
0.4 
(0.7) 
 
0.7 
(1.3) 
 
-0.2 
(1.5) 
 
 
 
 
39§ 
(1.1) 
 
-0.34 
(1.1) 
 
 
 
 
43 
(1.0) 
 
-0.2 
(0.9) 
 
3.0 
(0.4) 
 
0.5 
(1.2) 
 
45 
(1.6) 
 
-0.4 
(1.3) 
 
1.6 
(1.0) 
 
0.4 
(1.5) 
 
46 
(1.6) 
 
0.0 
(1.2) 
 
1.3 
(0.7) 
 
-0.1 
(1.3) 
*Weight for birth data only; aParameter means (SD), bParameter interval Δ (SD), cParameter 
interval velocity z-score; Student’s t-test significance levels §p<0.05, ‡p<0.001 
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Figure 1 Weight velocity z-score by gender 
 
 
Graph illustrating weight velocity z-score by gender in 3-month intervals. 
Student’s t-test to compare healthy to infants with CHD of same gender: males -1.82, p<0.001; 
females -1.80, p<0.001 
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Figure 2 Length velocity z-score by gender 
 
 
Graph illustrating illustrating length velocity z-score by gender in 3-month intervals. Birth  
length data not available. No difference between the groups. Student’s t-test to compare 
healthy to infants with CHD of same gender. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 58 
 
 
Figure 3 Head circumference velocity z-score by gender 
 
Graph illustrating head circumference velocity z-score by gender in 3-month intervals.  
Birth length data not available. No difference between the groups. Student’s t-test to 
compare healthy to infants with CHD of same gender. 
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CHAPTER 2 
Part 2 
Resting Energy Expenditure at 3-Months of Age in Infants Following Neonatal Surgery 
for Congenital Heart Disease 
Abstract 
Background:  Growth failure is well recognized in infants with Congenital Heart Disease 
(CHD).  Poor growth can impact physiologic and neurodevelopmental outcomes.  
 
Study Aim: To determine resting energy expenditure (REE), body composition and 
weight at 3-months of age in infants with CHD. A secondary aim was to identify 
predictors of REE.  
 
Design and Methods: Sub-analysis of a prospective, single center cohort with single 
ventricle (SV) and bi-ventricle (BV) physiology. Anthropometric measurements, REE, 
and body composition were obtained at 3-months. Analysis included chi-square for 
association between categorical variables, t-tests, ANOVA and ANCOVA to compare 
differences. Pearson’s correlation was used to examine linear relationships.  
 
Results: Of the 44 infants with CHD, 18% had SV physiology. Infants with SV and BV 
physiology had lower weight for age z scores compared to healthy infants -1.1 for SV 
(p=0.001) and  -1.0 for BV (p<0.005). Infants with SV and BV physiology had lower % 
body fat compared to healthy controls (SV 23.7%; BV 22.7%) but had similar REE as 
the control group. Fat free mass and infant age were positively correlated with REE. 
 
Conclusion: Cardiac physiology was not a predictor of REE kcal in this study sample. 
Infants with CHD had lower weight for age z score and decreased % body fat at 3 
months of age. These data suggest that inadequate caloric intake contributes to growth 
failure in infants with CHD. 
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Table 1 Definition of Terms  
 
  
Abbreviation          Term 
 
BV 
 
Biventricular Physiology 
 
CHD Congenital Heart Disease  
FM Fat Mass, kg  
FFM Fat Free Mass, kg  
REE Resting Energy Expenditure, Kcal/day 
%Sch Schofield equation percent predicted 
 
SV Single Ventricle Physiology  
%WHO WHO equation percent predicted 
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Introduction 
Growth failure is well recognized in infants with Congenital Heart Disease 
(CHD).  Despite surgical intervention in the neonatal period, more than 50% of these 
infants exhibit inadequate growth,1,2 with greater than 30% falling below the third 
percentile for weight early in life.3 Poor somatic growth in infancy has the potential to 
impact physiologic and neurodevelopmental outcomes well into childhood and 
adolescence.4,5 The etiology of poor growth in infants following neonatal surgery for 
CHD is likely multi-factorial and may in part result from inadequate energy intake or an 
increase in energy expenditure, resulting in an energy imbalance. Strong correlations 
have been demonstrated between growth failure early in life and long term cognitive 
deficiencies, including poor arithmetic performance, attention deficit, aggressive 
behavior and poor social and emotional development.4,5 We reported a high rate of 
growth failure at hospital discharge in infants with  both single ventricle (SV) physiology 
and biventricular (BV) circulation following neonatal surgery.6,7 Poor weight gain in the 
post-operative period prior to hospital discharge was associated with post-operative 
complications, and timing of initiation of nutrient intake. These findings are similar to 
other reports that suggest  infants with CHD receive less than adequate caloric intake 
to support normal weight gain and growth.8-14    
There have been multiple investigations into the energy needs of infants with 
CHD in the pre-operative and post-operative period. The results are mixed and may be 
due to study design, small sample size, or a diverse sample of infants with cardiac 
disease.15-23 The primary aim of this study was to determine whether there are 
differences in resting energy expenditure (REE), body composition, and somatic 
growth at 3-months of age in infants who have undergone neonatal surgery for CHD 
compared to healthy infants, and whether differences are present among infants with 
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CHD classified postoperatively as SV versus BV physiology.  A secondary aim was to 
identify predictors of REE in infants with CHD compared to healthy infants. 
Study Design and Setting 
This is a sub-analysis from a prospective, cohort study investigating predictors 
of growth in postoperative infants with CHD conducted at The Children’s Hospital of 
Philadelphia (CHOP) from March 2003 through May 2007. Study approval was 
obtained from the CHOP Institutional Review Board.  Informed consent was obtained 
from a parent or guardian of each participant prior to initiation of study protocol. 
Sample Population 
Study participants were recruited from the Cardiac Intensive Care Unit at 
CHOP.   Healthy infants served as the control group and were recruited from primary 
care practices, and the community at large. Eligibility for all infants included post-
menstrual age > 36 weeks and birth weight > 2500 grams. Infants with CHD who 
underwent cardiac surgical intervention during the neonatal period (first 30 days of life) 
and did not have known multiple congenital, facial, chromosomal or complex 
gastrointestinal anomalies or congenital and/or acquired neurological insults were 
eligible.  Infants were classified postoperatively as SV or BV physiology in accordance 
with established standards.24 Race and ethnicity of the infants were assigned by the 
parent’s self-identification. Families unable or unwilling to return to CHOP for study 
visits were not enrolled.  
Study Measurements 
 Measurements were obtained during the 3-month outpatient visit to the Clinical 
and Translational Research Center (CTRC). The measurements were obtained by 
research personnel according to standard protocol.25    
Anthropometric Measurements 
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Weight, length and head circumference measurements were obtained prior to 
measurement of REE and body composition on all participants. Weight was measured 
in kilograms (kg) using a scale accurate to 5 grams (Scaletronix, White Plains, NY, 
USA).  Infant recumbent length, was assessed using an infant length board (Holtain 
Limited, Crymuch, UK) accurate to 0.1 cm and head circumference was measured 
using a non-stretchable measuring tape accurate to 0.1 cm (McCOY Health Science 
Supply, Maryland Heights, MO, USA). Measurements were obtained in triplicate, the 
calculated mean was used in analysis. Birth weight was extracted from the transfer 
records accompanying the infant to CHOP and by parental report for the control group. 
All measurements were converted to z-scores using World Health Organization (WHO) 
standards.26   
Resting Energy Expenditure  
REE was measured in the CTRC by open-circuit indirect calorimetry using a 
canopy based computerized metabolic cart (Sensor Medic 2900 Z; Sensor Medics, 
Yorba Linda, CA, USA) in a thermal-neutral, noise-restricted environment. 
Measurements were performed during a minimum 30 minute period of infant sleep 
following an ad libitum feeding of breast milk or the infant’s usual formula given within 
one hour of the start of REE measurement. Infants who were device fed did not have 
feeds infusing during REE measurement. In infants, sleeping energy expenditure is 
used as a proxy for REE due to the practical considerations of measuring energy 
expenditure.27-29 The metabolic cart measures infant respiratory gas exchange of 
oxygen consumption (VO2) and carbon dioxide production (VCO2) in 1-minute intervals. 
The initial period of infant adjustment and any period of significant movement that 
altered REE were excluded from analysis. Studies with less than 15 minutes of usable 
data were eliminated from analysis. The remaining data points were averaged and the 
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modified Weir equation30 was used to calculate the REE. The results of the measured 
REE are expressed as kcal/day, and as a percent of the predicted values using 
Schofield (%Sch)31  and WHO (%WHO)32 equations. The Schofield equation adjusts for 
age, gender, weight and length, while the WHO equation adjusts for age, gender and 
weight. 
Body composition 
Body composition was measured using the Total Body Electrical Conductivity 
(TOBEC) instrument (TOBEC; model HP- Pediatric, 2 EM-SCAN, Springfield, IL), 33,34 
TOBEC  is based on a two-compartment model consisting of fat mass (FM) and fat free 
mass (FFM).  Infants were swaddled in a blanket to restrict movement with extremities 
extended and held parallel to the trunk of the body. The swaddled infant was then 
placed supine on the TOBEC sled. A minimum of five measurements were performed, 
the mean FFM and FM in kg and % body fat are reported.   
Statistical Analysis 
Statistical analysis was performed using SAS V9.2 (SAS Institute, Cary, NC). 
Infants with CHD were analyzed by SV and BV physiology classification to identify 
differences between the groups. In addition, the SV and BV physiology groups were 
compared separately to the healthy infants. Distribution plots were used to assess 
normality of all variables. Chi-square was used to test the association between the 
categorical variables. Descriptive statistics of the means, standard deviations, and 
minimum and maximum values for the continuous variables and computation of 
frequencies and percentages for categorical variables were calculated. Statistical 
significance was determined at the p<0.05 level. Two sided t-tests were used to 
compare mean differences in variables between the healthy and combined CHD 
physiology group and between each of the CHD physiology groups and healthy infants. 
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In addition, the mean difference between the SV and BV CHD physiology groups were 
compared using ANOVA.  Possible linear relationships between all continuous 
variables were examined using Pearson’s correlation coefficient. Additionally, 
Pearson’s correlations were used to explore linear relationships between the 
continuous variables and REE kcal/day, and to determine the independent variables to 
be included in a model to predict REE kcal/day.  Due to high correlation among many 
of the independent variables, the number of covariates in the regression model was 
restricted to minimize multicollinearity.  ANCOVA models were constructed to examine 
the differences in REE kcal/day for each CHD physiology group and among healthy 
infants while controlling for particular continuous covariates. The least squares means 
and the difference of the means were used to evaluate differences among the healthy 
and the CHD physiology groups. The variance of inflation factor, a measure of the 
degree of  multicollinearity present in the model was used to assess collinearity among 
the independent variables.35 All models tested had a variance of inflation factor <10, 
indicating multicollinearity was minimal in the models constructed. 
Results 
The study group included 93 infants with REE and TOBEC measurements. Of 
the44 infants with CHD, 17 (18%) had SV physiology and27 (29%) had BV physiology. 
There were 49 (53%) healthy infants in the control group. The distribution of cardiac 
primary diagnoses is presented in Table 1.  Characteristics of the study sample are 
presented in Table 2, and were similar between the control group, and the SV and BV 
groups. Mean age was similar between the groups at the 3-month visit (Table 3). 
Weight, length, head circumference (Table 3, Figure 1), and WHO z-score means were 
all significantly lower (p<0.05) in both the SV and BV physiology groups when 
compared to healthy infants, with the exception of length z-score of the BV physiology 
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group versus healthy infants (p=0.06).  The SV and BV physiology groups only differed 
in head circumference z-score; infants with SV physiology had smaller head size 
(p=0.03).   
The individual group means for REE kcal/day, %WHO REE, %Sch REE, FFM, 
FM, and % fat are shown in Table 3. Compared to healthy infants (27%), infants with 
SV (23.7%; p=0.04) or BV (22.7%; p<0.001) physiology had significantly lower % fat. 
REE as %WHO predicted was significantly higher in infants with CHD than in healthy 
infants (115, p=0.02).  REE as %Sch predicted was higher in the BV group versus 
healthy infants (112, p=0.02) but not in the SV versus healthy group. There were no 
differences in REE or body composition between the SV and BV physiology groups.  
From Pearson correlation analysis, REE kcal/day was significantly and 
positively correlated with FFM (r=0.71, p<0.0001), FM (r=0.44, p<0.0001) and age in 
days (r=0.31, p=0.003).  From the multiple linear regression models, the best 
predictors of REE kcal/day were FFM and infant age in days. The model that best 
predicts REE kcal/day in this study sample includes FFM, age in days, and SV and BV 
physiology and has an adjusted r2 =0.55 (Table 4). After adjusting for FFM and age in 
days, the differences in REE kcal/day between infants with either SV or BV physiology 
and healthy infants (reference group) were not significant. A model including FFM, FM, 
age in days and physiology was examined; however, FM was not significant in the 
presence of the other variables and did not contribute to the prediction of REE kcal/day 
for infants with CHD.  
Age was a significant covariate in each model tested. When age was removed, 
retaining FFM, and SV and BV physiology, there was a decrease in variance from 
r2=0.55 to r2=0.53 for predictors of REE kcal/day.  An interaction term for SV and BV 
physiology and FFM was tested but was not statistically significant, nor did these 
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interactions contribute to the prediction of REE kcal/day (data not shown). REE 
kcal/day increased significantly with increasing FFM (kg) in this study sample,  with no 
significant difference found in the slope of this increase among the three groups 
(healthy, SV, and BV).  
Discussion  
 In this study, we evaluated REE at 3 months of age in infants who underwent 
neonatal surgery for CHD compared to healthy infants. After adjusting for FFM and 
infant age in days, there was no difference in REE kcal in infants with SV or BV 
physiology compared to healthy controls. These findings do not support the clinically 
held hypothesis that post-operative cardiac physiology is a primary factor causing an 
increased REE kcal/day, contributing to delayed growth in infants with CHD.  Instead, 
these data demonstrate that body composition; specifically FFM and infant age were 
strong predictors of REE kcal/day in our study sample.  
 As expected, the strongest and most consistent contributor to REE kcal in this 
study was FFM.  As the metabolically active component of body composition, 
consisting of organs, muscles, skin, brain, bone, and supporting tissues, FFM is the 
major contributor to REE kcal.36-38  An increased amount of FFM leads to an increased 
REE per kg of body weight. The development of FFM during fetal life and early infancy 
is environmentally regulated and is contingent on nutrient intake.39 In our study sample, 
there was no difference in the mean FFM between the study groups. Despite its strong 
positive correlation (r=0.44, p=<0.0001) to REE kcal, total FM in kg, the most variable 
constituent of body composition in infancy was also not significant between the groups, 
nor did FM significantly contribute to the model predicting REE after adjusting for FFM 
and age.     
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The rapid weight gain, common in early infancy is due in large part to an 
increase in FM, which does not contribute significantly to REE kcal, likely related to the 
modest metabolic activity of fat tissue.36,40 Although total FM in kg did not differ 
between groups, % body fat was significantly lower in infants with CHD  when 
compared to healthy infants.  At birth, full term neonates have approximately 14 - 15% 
body fat.36 Fat accretion progresses rapidly in early infancy, and by 3 months of age, 
male infants have 25-30% body fat, and female infants have as much 32%.  .36,41 This 
rapid increase in the typically developing infant results from a positive energy balance, 
or energy intake that exceeds energy expenditure. Our data show the infants with CHD 
to be below the expected % fat gains for age. The decreased weight z-scores in  the 
infants with CHD are primarily due to reduced FM rather than FFM suggesting 
inadequate energy intake continues after hospital discharge.14 Insufficient energy 
intake to support a positive energy balance will lead to loss of FM and a decreased 
percentage of body fat per kg of body weight. This in turn commits a larger portion of 
the infant’s body mass to metabolically active tissue, FFM, resulting in an increase in 
REE kcal. Since the accretion of FM is directly related to energy intake, inadequate 
caloric and nutrient intake in these infants was likely responsible for a reduced 
accretion of fat and the decrease in % body fat. Our data show the infants with CHD 
physiology to be below the expected % fat gains for age. Previous work reported poor 
weight gain at hospital discharge,6,7 and findings of the current study demonstrate that 
poor weight gain persists between hospital discharge and 3 months of age. Modest 
improvement in caloric intake in infants with CHD will likely improve growth since there 
is no demonstrated burden of an excessive use of energy related to cardiac 
physiology.   
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Interestingly, we found infant age to be highly significant in the regression 
model (p=0.0006).  The wide age range in this study sample across all groups (71 – 
140 days) may account for the significance of age in the model.  In multiple models 
tested, infant age was consistently a significant covariate. These findings are similar to 
those of Puhakka et al19 who also found  age to be a significant predictor of REE kcal, 
in their cohort of 25 subjects with CHD whose ages ranged from 2-months to 10 years. 
   In the last two decades, we identified nine studies examining REE kcal in 
infants with CHD.15-23 A review of these studies and others by Nydegger and Bines42 
identified poor growth as a common occurrence in this patient population. Our study is 
unique in its approach to understanding energy expenditure in infants with CHD 
following neonatal surgical intervention. We compared a healthy control group to 
infants with CHD who underwent surgical intervention in the neonatal period, body 
composition was measured in all subjectsat  3 months of age, and all subjects with 
CHD were in their usual state of health at the time of study measurement.  
 Current clinical recommendations of energy requirements for healthy infants at 
3 months of age are approximately 95 kcal/kg/day across gender irrespective of 
formula or human milk intake.43  This recommendation is to provide a positive energy 
balance in an infant of appropriate size and body composition to support growth and 
activity compatible with good health.44,45 Our data demonstrate statistically significant 
differences in kg weight and weight z-score at 3 months of age in infants with CHD 
compared to healthy infants, this difference is primarily due to reduced percent body 
fat.  This deficit suggests that a moderate increase in caloric intake supporting the 
accretion of FM may increase the% body fat to meet energy requirements in infants 
with CHD, thus improving growth and development and decreasing the potential risks 
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of delayed neurobehavioral development, morbidity and mortality associated with poor 
growth in infancy.45,46 
Study Limitations 
 Study limitations included this being a single center cohort study our results 
cannot be generalized. A major limitation of this study is lack of caloric and nutrient 
intake data. Birth weight was obtained from the transfer record or from parent report 
and are not as accurate or reliable as those obtained at 3 months of age in the 
research setting. Lastly, there may be bias in that the families of infants who were 
sicker did not return for testing.  
Conclusion 
 Our findings refute the commonly held clinical view that postoperative cardiac 
physiology is a major factor in determining the energy expenditure of infants with CHD 
following neonatal surgical intervention. Infants with CHD had decreased weight z-
scores and percent body fat at 3 months, which is attributable to inadequate energy 
intake and not post surgical cardiac physiology. These data suggest intermittent 
measurements of body composition to accompany incremental growth measures may 
provide better information on growth and have far-reaching implications for healthcare 
providers to intercede in the nutritional support of those infants with CHD at risk for 
growth failure.  
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Table 1 Congenital Heart Disease diagnoses of study sample 
 
 
Primary diagnoses with post-operative physiology classification, depicted in percent of 
total subjects for each category. 
  
 Single-Ventricular Bi-Ventricular 
 % of n = 17 % of n = 27 
Hypoplastic Left Heart Syndrome 76  
Double Outlet Right Ventricle 12  
Tricuspid Atresia   6  
Valvular Aortic Stenosis   6  
D-Transposition of Great Arteries  33 
Coarctation of the Aorta  22 
Tetralogy of Fallot  19 
Valvular Pulmonary Atresia     7 
Total Anomalous Pulmonary Venous 
Return     7 
Interrupted Aortic Arch     4 
Ventricular Septal Defect     4 
Double Inlet Left Ventricle     4 
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Table 2 Sample characteristics of healthy infants and infants with Congenital Heart 
Disease.  
 
 
Sample distribution for gender, race and ethnicity with birth weight. 
 
  
 Healthy Infants Infants with Congenital Heart Disease  
  All Single Ventricle  Bi-Ventricle  
                         n 49 44 17 27 
Gender (%)     
 Male 
   Female 
63 
37 
61 
39 
71 
29 
56 
44 
Race (%)     
 African American 27  7  6   7 
 Asian  2  0  0  0 
 Caucasian 65 91 94 89 
 Other 6 2  0  4 
Ethnicity (%)     
 Latin/Hispanic   6   9  6 11 
 Non Latin/Hispanic 88 68 82 59 
   Other 6 23 12 30 
Birth Weight     
   kg  3.4 ± 0.5  3.4 ± 0.4  3.5 ± 0.3  3.3 ±  0.5 
   z-score  0.2 ± 1.0  0.2 ± 1.0  0.5 ± 0.6 0.0 ±1.0 
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Table 3 Growth, body composition and resting energy expenditure in all subjects at 3 
months of age. * 
 
 
*Results shown are means + SD.  Significance levels *p<0.05, **p<0.01, ***p<0.001 
show healthy infants compared separately to the combined and with each CHD 
physiology group; §p<0.05 depicts significance comparing the SV and BV CHD groups. 
 
  
 Healthy Infants Infants with Congenital Heart Disease  
  All      Single        Ventricle Bi-Ventricle 
 n 49 44        17 27 
Age at visit, days  95  ±  13  96 ±  13  99  ±  15  93 ± 11 
     
 Weight     
      kg  6.1 ± 0.8  5.6 ± 0.9 **  5.6 ± 1.0 **  5.5 ± 0.7 ** 
      z-score  -0.3 ± 1.0  -1.1 ± 1.1 ***  -1.1 ± 1.1 **  -1.0 ± 1.0 ** 
 Length     
      cm   61.4 ± 2.8  59.8 ± 2.3 ** 60.1 ± 2.1  59.6 ± 2.5 * 
      z-score      0.0  ± 1.2  -0.7 ± 1.1 *  -0.8 ± 0.9 *  -0.6 ± 1.2 
Head 
Circumference     
      cm   40.8 ± 1.3  39.7 ± 1.5 *** 39.2 ± 1.6 ***   40.0 ± 1.3 ** 
      z-score  0.3 ± 0.9  -0.6 ± 1.2 ***  -1.1 ± 1.3 ***  -0.2 ± 1.1 *§ 
     
Fat-free Mass, kg  4.4 ± 0.5  4.3 ± 0.5  4.2 ± 0.5  4.3 ± 0.5 
Fat mass, kg  1.7 ± 0.5  1.3 ± 0.4  1.4 ± 0.5  1.3 ± 0.3 
% Fat   27.0 ± 5.0  23.1 ± 5.1 ** 23.7 ± 5.5 *  22.7 ± 4.9 ** 
     
REE Kcal/day   328 ± 52  324 ± 55  325 ± 59  322 ± 54 
Schofield, % 
predicted  105 ± 13  112 ±   13 *  111 ± 14  112 ± 12 * 
WHO, % 
predicted  104 ± 13  115 ±   14 **  115 ±  17 *  114 ±  12 * 
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Table 4. Regression model of covariates with strongest contribution to REE kcal/day  
 
Model depicting contribution of FFM, age and cardiac physiology to REE kcal/day. 
Healthy infants are the reference group.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Parameter Standard Error t value p r2 
Intercept  -95.2  41.6  -2.3       0.02 0.55 
FFM, kg  72.7  7.3  9.8 <0.0001  
Age, days   1.6  0.3  3.6       0.0006  
SV  7.6  10.3  0.7       0.5  
BV  8.3  8.7  1.0       0.3  
n = 93      
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Figure 1 Box plot graph of growth measures at 3 months of age. 
 
 
  Legend:  
  N  for each group: SV – 17, BV – 27, Healthy – 49. 
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Figure 2 Regression line of REE kcal/day for fat-free mass (FFM), kg from TOBEC 
FFM, Kg
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Legend:  
              Single Ventricle                Biventricle                 Healthy 
The predicted line is calculated from an ANCOVA model using REE kcal/day as the 
dependent variable with FFM and physiology as independent variables. 
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CHAPTER 3 
The Use of Indirect Calorimetry (IC) to Measure Energy Needs in Mechanically 
Ventilated Children with Acute Lung Injury 
(Submitted as NIH Director’s Early Independence Award Application) 
Abstract 
Acute Lung Injury (ALI) is associated with significant morbidity and mortality in 
critically ill children. Annually, between 2,500 and 9,000 children are diagnosed with 
ALI, a condition of lung injury marked by diffuse pulmonary inflammation that leads to 
hypoxemia and respiratory failure. Characterized by acute onset, severe arterial 
hypoxemia, and diffuse bilateral pulmonary infiltrates, ALI can quickly progress, 
requiring mechanical ventilation for respiratory support and inciting a metabolic stress 
response. If not halted, these physiologic reactions to stress prolong healing and 
increase the risk for complications. In a critical illness such as ALI, optimal nutrition 
support is essential to diminish the metabolic response, support immune function, 
promote tissue repair, prevent loss of lean muscle mass, and eliminate weight loss. 
Current clinical practice uses prediction equations derived from measurements of 
healthy children and adults.  These equations tend to over- or underestimate energy 
needs and risk over- or underfeeding, threatening clinical outcomes. We purport that 
the use of Indirect Calorimetry (IC) to measure energy needs is superior to prediction 
equations and in fact, can help improve current nutrition management for critically ill, 
mechanically ventilated children with ALI. Our study will test the efficacy of using IC to 
accurately measure energy needs to the current practice of prescribing caloric needs 
based on the use of prediction equation calculations in critically ill, mechanically 
ventilated children with ALI. We hypothesize that compared to the use of standard 
prediction equations, energy requirements derived from IC measurements will improve 
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clinical outcomes, measured by increase in ventilator-free days, decreased weight loss, 
decreased loss of lean body mass, and decreased length of pediatric intensive care 
admission with an overall reduction in the length of hospitalization. 
Specific Aim 
ALI is associated with significant morbidity and mortality in critically ill children. 
Annually between 2500 and 9000 children are diagnosed with ALI,1 a condition of lung 
injury marked by diffuse pulmonary inflammation that leads to hypoxemia and 
respiratory failure.1-6 Characterized by acute onset, severe arterial hypoxemia, and 
diffuse bilateral pulmonary infiltrates, ALI can quickly progress, requiring mechanical 
ventilation for respiratory support and inciting a metabolic stress response.1 This 
metabolic response uses endogenous energy stores to provide for basic metabolic 
needs and support the ongoing stress response.7-10 If not halted, these physiologic 
reactions prolong healing and increase the risk for complications. In a critical illness 
such as ALI, optimal nutrition support is essential to diminish the metabolic response, 
support immune function, promote tissue repair, prevent loss of lean muscle mass, and 
eliminate weight loss.7,11 Research suggests that 16–20% and as high as 50% of 
critically ill children demonstrate significant protein energy malnutrition (PEM) within 48 
hours of admission, with continued deterioration during hospitalization.10-14 Current 
clinical practice using prediction equations derived from measurements on healthy 
children15,16 will likely over or underestimate energy needs, risking over or underfeeding 
and threatening clinical outcomes.15 We propose the use of IC to measure energy 
needs, which research suggests is superior to prediction equations to assess energy 
requirements and improve current nutrition management for critically ill, mechanically 
ventilated children with ALI. To improve clinical outcomes and decrease length of 
hospital stay providing specific caloric goals are vital to counter the metabolic response 
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to critical illness, increase ventilator-free days, minimize loss of lean muscle mass, and 
diminish weight loss for critically ill, mechanically ventilated children with ALI.17     
Innovation and Impact 
The caloric needs of critically ill children with ALI are related to the energy 
burden imposed by the metabolic response to the inflammatory process and the 
severity of illness.7,18 We suggest that measurement of energy expenditure by IC will 
prove to be an accurate method to assess energy needs of critically ill children with 
ALI. Current practice, the use of standard prediction equations with or without a stress 
factor, are likely to over or underestimate energy requirements in critical illness,14,19-23 
with the potential to prolong mechanical ventilation, increase the risk of infection, and 
extend hospitalization due to prolonged recovery.24 To date, we are not aware of 
clinical investigation assessing energy requirements for a specific disease in critically 
ill, mechanically ventilated children in an intensive care unit. This study may reveal 
energy requirements not previously acknowledged by critical care providers for 
critically ill children with ALI. Indirect Calorimetry can provide precise information about 
energy needs for children with ALI to optimize nutrition support and minimize the 
caloric imbalances often incurred from use of prediction equations. This approach to 
energy needs assessment has high potential for clinical implementation and has the 
capability to shift clinical practice paradigms of nutrition management in the Pediatric 
Intensive Care Unit (PICU) environment. Our study will test the efficacy of IC in 
critically ill, mechanically ventilated children with ALI to assess energy requirements 
and inform prescription for caloric goals. IC will be assessed during the acute, plateau, 
and weaning phase of mechanical ventilation. In contrast to prediction equations, 
accurate measurement of energy expenditure can provide more precise information to 
determine specific caloric needs, inform clinical practice and assist decision-making for 
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nutrition support. This randomized, controlled clinical trial will compare IC 
measurements to the current clinical practice, use of prediction equations to determine 
energy needs, and examine outcomes specifically related to critical illness and 
mechanical ventilation in children with ALI.  
Primary Aim 
To compare the effect of using Indirect Calorimetry to determine energy 
requirements in critically ill, mechanically ventilated children with Acute Lung Injury to 
the current clinical practice of prescribing energy needs by the use of prediction 
equation calculations.   
Hypothesis 
Compared to the use of standard prediction equations, energy requirements 
derived from Indirect Calorimetry measurements for critically ill, mechanically ventilated 
children with Acute Lung Injury will improve clinical outcomes as evidenced by: 
1) Increase in ventilator-free days 
2) Decreased weight loss 
3) Decreased loss of lean body mass  
4) Decreased length of Pediatric Intensive Care Unit hospitalization  
Background and Significance 
Acute Lung Injury  
Acute lung injury (ALI) is a condition marked by diffuse pulmonary inflammation that 
leads to hypoxemia and respiratory failure in both children and adults.1-6 It is associated 
with high mortality, morbidity, and an increased use of intensive care resources with 
significant financial burden.1-3 Characterized by acute onset, severe arterial hypoxemia 
resistant to oxygen therapy, and diffuse bilateral pulmonary infiltrates without evidence 
of left atrial hypertension, ALI has a variety of triggers and risk factors, the most 
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common being infection in the pulmonary airways and parenchyma.1,25 In the United 
States, between 2,500 and 9,000 children are diagnosed with ALI annually, constituting 
between 1– 4% of all Pediatric Intensive Care Unit (PICU) admissions.1,26 The high 
volume of children with ALI, severity of the disease, and potential for increased 
morbidity make this a suitable illness to investigate energy needs for a subgroup of 
critically ill children requiring mechanical ventilation. Approximately 63% of children 
have more than one risk factor for developing ALI, a rate similar to that found in 
adults.25 These factors include direct lung injury (51% pulmonary infection, 12% 
pulmonary aspiration, 3% near drowning) and indirect lung injury (43% sepsis 
syndrome, 40% multiple transfusions in close proximity, 10% post-bone-marrow 
transplantation, 8% non-thoracic trauma). Mortality associated with ALI is reported to 
be as high as 18–35% in children.5 Due to the severity of the pulmonary disease, 
children with ALI often quickly progress to respiratory failure requiring endotracheal 
intubation and mechanical ventilation. The disease process and respiratory failure 
activate an acute alteration in metabolic status and trigger initiation of the stress 
response and the ensuing catabolism inherent in the process. Characteristics of the 
disease, the ensuing respiratory failure requiring mechanical ventilation, the metabolic 
stress response, and decreased energy intake put these children at risk for alterations 
in energy balance, PEM and its consequences leading to a prolonged PICU stay and 
extended hospitalization.1,4 Despite its frequency as a diagnosis in the PICU population 
and its severity, we have not found an investigation specifically designed to assess the 
energy needs of critically ill, mechanically ventilated children with ALI. The severity of 
illness, metabolic response to lung injury, alterations in caloric requirements, and 
decreased energy intake are dynamic factors that potentially make the use of  standard 
prediction equations inconsistent with actual energy needs; the use of IC is a more 
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accurate method to assess energy needs and prescribe appropriate caloric intake. It 
follows that children with ALI requiring mechanical ventilation and supportive care will 
benefit from early, accurate assessment of energy needs and nutrient prescription for 
appropriate caloric goals to decrease the harmful effects of catabolism resulting from 
the metabolic response to critical illness.   
Metabolic Alterations in Critical Illness 
Metabolic alterations that accompany critical illness occur in proportion to the 
magnitude of the illness and the pre-illness nutrition status. It is not always possible to 
predict the child’s response to illness owing to the range of illness onset, its intensity, 
and its duration. The metabolic response to critical illness is variable, and includes 
hormonal and cytokine profiles that influence the overall energy burden.7,10,27 
Characterized by an elevation of serum hormone levels of insulin, glucagon, growth 
hormone, and cortisol and combined with the release of catecholamines and cytokines, 
the stress response results in catabolism of endogenous supplies of protein, fat, and 
carbohydrates. This process provides energy for both basal metabolism and the 
metabolic requirements incited by the presenting illness.10 Typically, the metabolic 
response to stress induces muscle protein breakdown that results in increased 
circulation of free amino acids, some of which are used for tissue repair. Those free 
amino acids not used in repair are redirected through the liver and become involved in 
the production of glucose through gluconeogenesis. The increase in circulating serum 
glucagon levels may deplete the limited endogenous stores, increasing reliance on 
gluconeogenesis from non carbohydrate substrates (e.g. lactate).10,27 In addition, 
cytokines mediate fat metabolism, causing increased fatty acid oxidation, resulting in 
hypertriglyceridemia and lipid intolerance. Ketone production results from lipolysis to 
provide energy and protection for the brain to maintain its uninterrupted and large 
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supply of glucose.27 It is common for children to have a delayed response to nutrition 
support, this predisposes them to develop malnutrition from the metabolic response to 
stress faster than adults.8 The administration of exogenous substrate of glucose does 
not stop gluconeogenesis, and alteration in carbohydrate metabolism continues;27 
however, the combined provision of glucose and protein may blunt the process by 
supporting protein synthesis.7 The ability to utilize exogenous energy substrate and 
synthesize new proteins is a critical aspect of recovery from critical illness and 
resumption of normal metabolic processes. The capability to accurately assess caloric 
needs and prescribe appropriate energy goals may facilitate early protein synthesis. 
Given these alterations in the metabolic process with critical illness, and the severity of 
illness seen in children with ALI requiring mechanical ventilation, it is conceivable that 
PEM would complicate the disease process, delay recovery, and increase the length of 
hospitalization.15 Overall, the metabolic response in ALI results in increased protein 
breakdown and lipid and glucose intolerance. This combination of reactions, along with 
suboptimal nutrition support, puts the critically ill child at high risk for weight loss, loss 
of lean body mass, and an exacerbation of malnutrition that can worsen disease 
progression.10,27 
Suboptimal Nutrition Support in Pediatric Critical Illness 
Nutrition support during critical illness such as ALI is challenging. The potential 
risk of malnutrition and caloric imbalance can lead to PEM, which is associated with 
altered physiologic response(s), impaired cell-mediated immunity, and loss of lean 
body mass.9,22 Acute PEM in critical illness is multifactorial, owing to the dynamic range 
of metabolic alterations, the child’s age, and severity of illness.7,12,28 It is difficult to 
determine if the degree of illness contributes to a poor nutrition status or if a poor 
nutrition status contributes to the severity of illness. The metabolic response to critical 
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illness cannot be prevented solely by nutrition support; however, suboptimal nutrition 
accompanied by critical illness may contribute to prolonged alterations in metabolism 
and exacerbate the stress response.  
The effects of PEM in critically ill children were noted over two decades ago by 
Pollack et al,29 who demonstrated acute PEM in 16% of their heterogeneous sample of 
50 children admitted to the PICU; the condition was associated with clinical instability, 
increased use of PICU resources, and higher rates of mortality. More recently, Hulst 
and colleagues30 demonstrated a cumulative energy deficit of 100 kcal/kg and a 
cumulative protein deficit of 10 gm/kg, which explained 39% and 40%  of the respective 
change in kilogram weight and lean body mass in their cohort of 98 mechanically 
ventilated children. Despite advances in clinical care, the challenges of nutrition 
support for children during critical illness identified in the 1980s persist.7-9,29,31,32  
The lack of recognition and knowledge by care providers to the unique and 
complex energy needs of the critically ill child add to the challenges of providing 
adequate caloric intake during critical illness.7,29 In a recent study of 33 PICU subjects 
with various diagnoses, Mehta and colleagues15 demonstrated failure of physicians to 
accurately predict the metabolic status of the children studied, supporting the idea that 
providers are unaware of metabolic requirements in critical illness. The researchers 
deduced this was a contributing factor to overestimation of energy needs and 
subsequent overfeeding in their study sample.15 This lack of accuracy in energy 
assessment puts critically ill children such as those with ALI at risk for overfeeding or 
underfeeding, either of which can contribute to acute PEM and potentiate infectious 
and non-infectious complications, alterations in normal physiologic response to illness, 
additional use of PICU resources, increased financial burden and can add to morbidity 
and mortality.7,12,13,15,33,34  
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Lack of energy intake or underfeeding has been associated with gastrointestinal 
mucosal atrophy, heightening the subject’s susceptibility to infection, delayed wound 
healing, muscle weakness prolonging the need for mechanical ventilation, diminished 
cardiac reserve, and immune system dysfunction.7,9,12,14,33,35,36 Alternatively, 
overfeeding can result in increased carbon dioxide production prolonging mechanical 
ventilation, alteration in hepatic function, and variation in glycemic control.7,8,12,17,33,36 
Either condition can be potentially life threatening for the mechanically ventilated child 
with ALI who has a compromised respiratory status. Studies suggest that critically ill 
children who receive adequate nutrition support experience early physiologic stability 
and improved outcomes.8,35 The American Society for Parenteral and Enteral Nutrition 
(A.S.P.E.N.) acknowledges that investigations specific to critically ill children are 
necessary to guide nutrition support.18,22 Recently published guidelines for nutrition 
support in critically ill children concede the inaccuracy of predictive equations to 
estimate energy needs and suggest further investigation on the use of IC as a method 
to accurately assess energy expenditure and guide energy prescription for critically ill 
children.15,22  
Determining Energy Needs: Predictive Equations and Indirect Calorimetry 
Energy requirements in children are derived from standard prediction 
equations. The equations frequently used in pediatrics include those developed by 
Harris-Benedict, Talbot, Schofield, the Food and Agriculture Organization/World Health 
Organization/United Nations University (FAO/WHO/UNU), and the Recommended 
Dietary Allowance (RDA) predictions.6,17,37,38 The Harris-Benedict equation was based 
on measurements in 97 infants under one month of age and more than 200 
adolescents.20,39 Talbot developed energy estimates from data obtained through 
repeated measures on healthy infants and children (the same participants) combined 
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with previously published studies.40 Schofield refined the initial predictive equations, 
including those developed by Talbot, and constructed equations using weight, height, 
and gender across age groups.41-43 The RDA is an estimate of the minimum average 
daily intake necessary to meet nutrient requirements of healthy individuals across 
gender and age.38  
Studies conducted in heterogeneous PICU populations have shown 
incongruence between measured energy expenditure and prediction equations. 
Thomson et al44 demonstrated inaccuracies between the Harris-Benedict and Schofield 
equations when compared to measured energy expenditure in both healthy and ill 
infants. Coss-Bu et al45 found large differences between the Harris-Benedict and Talbot 
equations, with and without use of a correction stress factor, when compared to IC 
measurements in critically ill, mechanically ventilated children. Briassoulis and 
colleagues17 found energy expenditure measured by IC to be significantly lower than 
energy expenditure derived from prediction equations. Other researchers have found 
under and overestimation of energy needs when using prediction equations and 
endorse the use of IC to accurately assess energy needs and prescribe realistic caloric 
intake goals for critically ill children.1,9,19,23,24,33,46,47 Many of the studies cited do not 
address assessment of body composition as part of IC measurement. However, 
determination of body composition is necessary for the judicious interpretation of 
prediction equations and IC measurement. It is the variation in fat-free mass that may 
explain a large component of energy needs, in that energy expenditure may be 
decreased in children with a higher percentage of fat-free mass per kilogram of body 
weight.48 The respiratory quotient (RQ) is another important marker obtained from IC 
measurement. The RQ thought to be indicative of substrate use is a ratio derived from 
carbon dioxide production (VCO2) to oxygen consumption (VO2) with an acceptable 
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range of 0.85 to 1.0 in children. Used to substantiate the validity of IC measurements, 
an RQ above 1.0 may indicate overfeeding, while less than 0.85 may be a sign of 
suboptimal energy intake. Applicability of the RQ in critical illness is limited owing to 
alterations in metabolism, a compromised respiratory status, and its reported low 
sensitivity and specificity in both adults and children.28,49 De Klerk et al35 found the RQ 
in mechanically ventilated, critically ill children to indicate underfeeding in 45% of their 
study sample and overfeeding in 15%. These researchers suggest RQ measurements 
combined with IC measurements may be a better approach to assessment of energy 
needs in critically ill children.35  
Current Practice for Derived Energy Requirements 
Investigations into energy requirements in critically ill children overwhelmingly 
suggest inaccuracy of prediction equations to estimate energy needs.17,22-24,33,46,47,50 In 
a recent study by Mehta and colleagues19 there was poor agreement between 
equation derived energy needs and IC measured energy expenditure, resulting in a 
high incidence of overfeeding and underfeeding, in their study sample, based on the 
equations alone. Challenges with the use of these equations lie in the fact that they are 
based on demographics from healthy children under conditions of usual environment 
and physical activity16 and they do not account for the shifts in energy requirements 
that accompany critical illness. Energy normally used for tissue accretion and growth is 
used for tissue repair and glucose generation in critical illness; there is minimal 
physical activity; and there is a transient cessation of growth during critical illness that 
alters energy requirements.7,16,17,30 The metabolic response that is proportional to the 
severity of illness can trigger changes in energy metabolism that work to counteract the 
stress response while simultaneously lending support to basal metabolic function7; 
prediction equations cannot adjust for these changes. This is particularly true for 
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critically ill children with ALI whose energy needs may be significantly altered, and in 
whom inaccurate assessment of needs may lead to overfeeding or underfeeding and 
affect an already compromised metabolic and respiratory status. In the PICU at The 
Children’s Hospital of Philadelphia (CHOP), energy requirements are derived by 
prediction equations. Dedicated PICU nutritionists primarily use the RDA for children 
less than 1 year of age and the World Health Organization (WHO) equation for children 
over 1 year. If the child is overweight and a length or height measurement is available 
the Schofield equation is applied, lastly, in the case of an older adolescent or young 
adult the Harris-Benedict equation is used to calculate energy requirements (personal 
communication: M. Nagel RD, LDN, CNSD, S. Seiple, RD, LDN, CNSD; January 12, 
2011). Based on calculations derived by one of the aforementioned equations, 
prescriptions for caloric intake are generated. The child’s progress is followed and 
adjustments for energy needs are made based on clinical status, laboratory results, 
and respiratory progress. The decision to increase calories by use of a stress factor is 
made by the clinical nutritionist in discussion with the critical care team based on age, 
history,and  severity of illness. Using IC to determine specific energy requirements and 
prescribing such for critically ill, mechanically ventilated children with ALI can achieve 
optimal nutrition support and avoid caloric imbalances often incurred with the use of 
prediction equations.  
Research Design and Methods 
Study Overview   
This study is a two-group randomized, controlled clinical trial that compares 
energy requirements derived from IC measurement of energy expenditure to the 
current practice of energy requirements derived from standard prediction equations. 
After obtaining informed consent, subjects diagnosed with ALI will be randomized to 
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either the study or control group.  The study group will  receive IC measurements in 
addition to prediction equation calculation for energy requirements, versus the  control 
group who will maintain the current practice of sole use of prediction equation 
calculations to derive energy needs. Prediction equations, as described above, will be 
calculated for all study participants to evaluate differences between IC measured 
energy needs and energy needs derived from prediction equations. Those participants 
who receive IC measurements will have their prescription for energy intake based on 
the IC measurement and will receive caloric intake based on this measurement for the 
duration of the study period. Participants whose energy needs are assessed by 
prediction equation will have energy intake prescriptions generated accordingly. All 
intake will be recorded and assessed daily for caloric content and total fluid volume for 
each child participating in the study. This will include all intravenous fluids, glucose 
containing base solutions for medications (enteral or intravenous), and enteral or 
parenteral nutrition. All participants will have anthropometric measurements of weight, 
supine length, and head circumference (if 5 years of age or younger). In addition, 4 
skinfold measures including subscapular, tricep, bicep, suprailiac, and a mid upperarm 
circumference will complete the anthropometric data set. These measurements will be 
obtained upon study enrollment, prior to each IC measurement and at PICU discharge 
or day 28 of study participation, whichever occurs first. Study participation will end at 
28 days regardless of whether the participant remains mechanically ventilated or 
remains in the PICU. The Acute Respiratory Distress Syndrome network defines 
ventilator-free days (VFD) as the number of days from study enrollment to day 28 
during which there is unassisted spontaneous breathing for 48 consecutive hours.51 All 
participants will receive usual PICU care for ventilator and supportive management. 
Usual PICU care includes extubation readiness testing (see appendix). 
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Figure 1 Randomization Schema 
 
 
Eligibility and Recruitment 
Study Setting 
The sample will be drawn from children admitted to the PICU at CHOP. This is 
an internationally recognized clinical, critical care research center with a 54-bed 
multidisciplinary intensive care unit that admits more than 3,000 critically ill children 
annually. Age of children admitted to the PICU ranges from neonatal (28 days) to 18 
years. The RESTORE clinical trial (U01HL086622; U01HL086649; Principal 
Investigator: Martha A. Q. Curley, RN, PhD) is currently recruiting intubated and 
ventilated participants with acute respiratory failure from the PICU at CHOP. In the 
most recent 18 months, 108 participants consented and enrolled, 37% of whom had a 
diagnosis of ALI. These data support the feasibility of recruitment for the current 
proposal.    
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Study Sample 
Children admitted to the PICU and diagnosed with ALI will be screened for 
study eligibility and participation. Parents or legal guardians will be approached for 
consent if their child meets study criteria. All participants will be children with a 
diagnosis of ALI requiring mechanical ventilation, who are at least 44 weeks post 
conceptual age but have not yet reached their 19th birthday. Given that all participants 
will be intubated and mechanically ventilated, it is anticipated that subjects will not be 
able to provide assent to participate in the study. The exclusion criteria are designed to 
eliminate potential participants with conditions known to alter basal metabolism and/or 
conditions that can lead to inaccurate IC measurement results. Study exclusion criteria 
include infants less than 44 weeks post conceptual age owing to typical physiologic 
changes of the premature newborn that require increased energy, children with chronic 
pulmonary disease and those with known chromosomal abnormalities.  In addition, 
children with illnesses that result in a compromised respiratory or pulmonary status 
known to have alterations in energy requirements at baseline or the presence of air 
leak through chest tube(s) causing inaccurate IC measurements are ineligible for 
enrollment.52 Table 1 specifies inclusion and exclusion criteria. 
Randomization   
Once informed consent is obtained, study participants will be randomized at 
enrollment to receive IC measurements in addition to having energy needs calculated 
with prediction equations (intervention group) versus current practice for use of 
prediction equations alone. Randomization will be performed using a permuted block 
design with random block sizes53 to ensure an equal allocation of participants to both 
the intervention and control groups throughout the study. Allocation will be concealed 
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using serially numbered, opaque sealed envelopes containing study assignments. The 
randomization schema is presented in Figure 1. 
 
Table 1 Inclusion and Exclusion Criteria 
 
 
  
Inclusion Criteria Exclusion Criteria 
• At least 44 weeks 
postconceptual age but have 
not yet had their 19th birthday  
 
• Diagnosis of acute lung injury:  
Intubated and mechanically 
ventilated with a ratio of partial 
pressure of arterial 
oxygen((PaO2) to the fraction 
of inspired oxygen (FIO2) of 
300), bilateral pulmonary 
infiltrates, and no clinical 
evidence of left atrial 
hypertension 
 
• Intubated with a cuffed or 
uncuffed entdotracheal  tube 
with negligible air leak ≤ 5% 
difference between inspired 
and expired tidal volumes 
 
 
 
• Chromosomal abnormalities 
(known or suspected) 
• Metabolic disorders (known or 
suspected) 
• Congenital heart disease  
• Severe brain injury  
(Glasgow coma scale <8) 
• Presence of chest tube(s) with air 
leak 
• Supported on extracorporeal 
membrane oxygenation (ECMO) 
or High Frequency Oscillatory 
Ventilation (HFOV) 
• History of/presence of  oxygen 
and/or diuretic dependent chronic 
lung disease  
• Upper airway diseases 
(e.g. bronchial / tracheomalacia,  
• Neuromuscular respiratory failure 
(e.g. spinal muscular atrophy) 
• Chronic ventilator dependence 
• Agreement that continued 
treatment is futile  
• Concurrent participation in any 
other clinical trial 
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Power Analysis 
Based on preliminary data, we estimate the overall median numbers of 
ventilator-free days (VFD) in the control group to be 21, recognizing that these data are 
skewed consequential to assigning zero VFD to participants censored at the end of 
their stay. As such, group sample sizes of 50 each will achieve 80% power to detect a 
difference of 3 days between the groups (21 verses 24 VFD). The estimated group 
standard deviations are assumed to be 4.0, along with a significance level (alpha) of 
0.01 to account for multiple outcomes. This calculation is based on a two-sided Mann-
Whitney U test.  
Attrition 
Although attrition is expected to be minimal in this study, we will enroll 10 
additional participants in each group to accommodate for participant dropout. Some 
parents may opt to withdraw their child from the study. In addition, some participants 
may improve rapidly and not provide 3 data points while other participants may 
become too ill for 3 data points, or may not be able to tolerate the recommended 
calories prescribed from IC measurement. Data will be analyzed with an intention-to-
treat analysis. Based on these assumptions, a completed data point is defined as one 
completed IC assessment, with anthropometric measures and participant capability to 
tolerate the caloric load recommended by the IC measurement. Nutrition support can 
be delivered via either the enteral or the parenteral route; either route may be used for 
the IC recommended caloric load to meet study completion criteria.      
Study Procedures 
The following section includes a discussion of the research protocol for the 
proposed study. The major variables, their measurement, and the data analysis plan 
are presented. Study measurements are outlined in Table 2.  
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Participant PICU Measurements   
Measurements of weight, length, and head circumference are obtained by the 
Principal Investigator (PI) and /or Research Assistant (RA), the results will be shared 
with the clinical staff. Weight measured in kilograms will be obtained on all potential 
participants on admission to PICU in weigh bed scales (Stryker Medical, Portage, MI) 
or infant weigh cribs (Hard Manufacturing Company, Buffalo, NY). If not admitted to a 
weigh bed or crib, a weight will be obtained on the appropriate infant pan scale 
(Scaletronix, White Plains, NY) or sling scale (Scaletronix, White Plains, NY) for age 
and size. Head circumference is measured on subjects 5 years of age or less (protocol 
of CHOP Nutrition and Growth Lab) using a non stretch, fiberglass tape measure. 
Three measures are taken repositioning the tape between each measure; the mean of 
the measures is recorded and used in analysis. Supine recumbent heel-to-crown 
length will be measured on all subjects using flexible, non stretch measuring tape and 
a stabilization board at the foot to optimize measurement.   
Anthropometric Measures  
Body composition, total fat-free mass, fat mass, and percent body fat will be 
assessed by 4 skinfolds and a mid upper-arm and mid calf circumference using 
prediction equations adapted for children and adolescents.54,55 All anthropometric 
techniques will follow those described by Lohman et al56 and be performed by a trained 
research anthropometrist. Anthropometric measurements will be assessed prior to or 
following each IC measurement. Skinfold thickness to 0.1 mm will be measured at the 
subscapular, tricep, bicep, and suprailiac sites with a skinfold caliper (Holtain, 
Crymych, UK) to assess subcutaneous fat stores. Mid upper-arm and mid-calf 
circumference will be measured with a non-stretch fiberglass tape to 0.1 cm (McCoy, 
Maryland Heights, MO). All measurements will be taken and recorded in triplicate with 
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the mean used in analysis. Lange and Holtain skinfold calipers, sliding calipers, 
abdominal caliper, and anthropometer, and a knee-height  measuring device for 
assessment of short-term growth are used for measurements. Anthropometric 
equipment is checked and calibrated before every assessment to assure proper 
operation. 
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Table 2 Study Measurements  
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Prediction Equation Calculation 
 The PI and the clinical nutritionist will calculate energy needs based on an 
appropriate equation for the participant’s age, gender, weight, stature and clinical 
status. The Schofield,41 WHO,57 and RDA58 equations are used most often in our PICU 
at CHOP and will be used for this study  Parameters to use in the calculations are 
specified by the equation. 
Fluid and Nutrient Intake  
All nutritional and non-nutritional intake will be retrieved from the clinical flow 
sheet as documented by the bedside nurse and recorded daily for each enrolled 
participant. Caloric and fluid intake and fluid balance will be followed daily for the 28-
day study period. Prescriptions for nutrient intake based on the recommendations of 
the clinical nutritionist and prescribed by the provider clinically responsible will be 
checked in the electronic medical record order system and documented by the RA in 
the study clinical database. With few exceptions, nutrition support can be delivered to 
critically ill children by either the enteral or the parenteral route or both. The enteral 
route is preferred as it is the most physiologic, allowing stomach and bowel digestion 
and absorption of nutrients. In the critically ill child, however, enteral intake may not be 
possible for various reasons. Following IC measurements, the clinical nutritionist will 
reassess the initially prescribed intake and make adjustments as indicated for 
participants in the study group. The adjusted recommendations for energy intake made 
in accordance with the IC measurements 
will be communicated to the responsible prescriber and prescription changes made 
accordingly. All energy intake inclusive of changes will be recorded daily for all 
participants.  
Indirect Calorimetry Measurement 
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Using IC, resting energy expenditure (REE) and the respiratory quotient (RQ) 
will be assessed during the participant’s acute phase, plateau phase, and weaning to 
extubation phase of illness. Individual time points allow the intervention to be driven by 
the participant’s clinical status. In the acute phase of ALI, which commences with the 
onset of respiratory insufficiency, measured by an increasing ratio of the partial 
pressure of arterial oxygen to the fraction of inspired oxygen (PF ratio), equal to 300 
mmHg or less and requires ventilator support, is when alterations in metabolism may 
be heightened. During this time, accurate assessment of energy requirements is 
necessary to provide adequate calories to minimize loss of lean body mass and 
minimize the catabolic effects that can occur with the metabolic stress response. 
During the plateau phase, when ventilator settings have not escalated in the previous 
24 hours, metabolic requirements may change and adjustment of caloric goals will 
minimize the potential to over- or underfeed. At the point of weaning ventilator support 
(the weaning phase) characterized by a progressive reduction in ventilator settings in 
the preceding 24 hours, energy needs may again change, and an adjustment in 
calories may be necessary.59   
IC measurements will be obtained using a portable computerized metabolic cart 
(Vmax SPECTRA (29s), Viasys Healthcare/Sensormedics, Yorba Linda, CA). The PI, a 
pediatric critical care nurse practitioner, or a critical care trained physician will assess 
the participant for hemodynamic and respiratory stability prior to initiation of IC 
measurements. For the purposes of this study, respiratory stability is defined as no 
escalation in ventilation within 4 hours of IC measurement, no ventilation changes 
within 1 hour prior to IC measurement, acceptable oxygen saturation and end tidal 
carbon dioxide levels (based on preceding 4-hour trend), equal bilateral breath sounds 
with equal aeration and chest rise, absence of retractions, and no overt signs of 
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respiratory distress (cough, excessive movement, pain, etc). Participants will be 
assessed for a leak in the ventilator circuit that is 5% or less between measured 
inspiratory and expiratory tidal volumes. Pain will be assessed by the PI using the 
Faces, Legs, Activity, Cry and Consolability (FLACC) scale,60 cross-checked with the 
bedside critical care nurse and both scores recorded. A score of 0–3 indicating none to 
mild pain is necessary for the IC measurement to commence. If the FLACC scale score 
is 3 or greater, the IC measurement will be postponed until the participant is in a 
resting, comfortable state.   
A registered respiratory therapist (RRT) trained in the care of critically ill, 
mechanically ventilated children at CHOP will be present for the duration of each IC 
measurement. In mechanically ventilated participants, an adapter is used to attach the 
flow sensor of the metabolic cart to the exhalation outlet of the ventilator. This adapter 
will be secured by the RRT and the participant will be reassessed for continued stability 
and any changes in respiratory or ventilation status. Anticipating the possibility of lung 
volume loss with attachment of the adapter, usual PICU procedures for managing lung 
volume loss will be instituted and followed. For the entirety of each IC measurement on 
each participant, a respiratory therapist, a critical care nurse specially trained in the 
care of critically ill children requiring mechanical ventilation, the PI, and/or a critical-
care-trained physician will be in attendance.  Should the participant exhibit any sign of 
distress or clinical instability during IC measurement, the assessment will be 
immediately aborted. Usual PICU care for safety will be maintained during IC 
measurement, including but not limited to checking security and patency of the 
endotracheal tube, continuous electronic hemodynamic monitoring and continuous 
observed patient assessment. During each IC measurement, the environment will be 
controlled in the usual manner as that used during an invasive or high-risk procedure in 
 108 
 
the PICU. Previous studies have not reported any serious adverse events associated 
with IC measurements in mechanically ventilated children or adults.17,19,35,45,61 
Following a well-established protocol from the Nutrition and Growth Laboratory 
of Dr. Virginia Stallings at CHOP, an age-appropriate fast according to institution 
standards will be instituted prior to each IC measurement. Every attempt will be made 
to perform IC measurements between 6 a.m. and 10a.m. with the participant resting 
and pain-free. Once the specified assessments are complete and the participant 
determined clinically stable for IC testing, a 60-minute test will be performed. In 
accordance with Dr Stallings’ protocol, 60 minutes is necessary to allow collection of an 
adequate number of time points to ensure technical quality of the test, allow a period of 
steady-state to commence, and have enough time measurements to assure quality 
data collection for each IC measurement. Steady-state is defined as a period of time 
after the start of the measurement with 10% or less variation in VO2 and VCO2 and a 
5% or less variation in RQ measurements.62-64 Data from the first 10 minutes and 
during periods of significant physical movement, coughing or agitation are eliminated, 
with the remaining data averaged for the mean REE and RQ. REE is then 
electronically calculated using the modified Weir equation and expressed in 
kilocalories. REE from IC is then compared to values derived from prediction equation 
calculations. The WHO equation adjusts for age, gender and weight,57 while Schofield 
adjusts for age, gender, weight, and height.41 Fat-free mass will be assessed from 
skinfold measures to determine its contribution to the REE.  
Study Burden 
We anticipate minimal study burden as all measurements are planned during 
admission in the PICU. The degree of burden will be in a family’s decision to 
participate. The study procedures will not interfere with any usual PICU care or 
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procedures nor will it prevent participants transferring out of the intensive care unit 
once they are clinically stable.  
Study Safety 
Safety of study procedures will be monitored for all study participants. There will 
be strict adherence to study protocol with continuous electronic hemodynamic 
monitoring in addition to continuous observation during the IC measurement by a 
critical care provider (PI or critical-care-trained physician), critical care RRT, and the 
critical care nurse. PICU precautions for maintenance of lung volume will include the 
use of inline adapters and all usual maneuvers to minimize loss of lung volume when 
the participant is disconnected from the ventilator circuit. Should a decrease in lung 
volume occur, usual PICU maneuvers for re-recruitment will be employed. Participants 
are monitored for respiratory and hemodynamic stability as well as environmental 
safety throughout each IC measurement and throughout the study period. 
Measurement of Study Outcomes 
Study outcome is to compare the effect of using IC to determine energy 
requirements in mechanically ventilated children with ALI to the current practice of 
prescribing energy needs by the use of prediction equations. IC measurements as 
proposed are useful for directing prescriptions for energy intake. This, we propose, will 
result in: 
1) Increase in ventilator-free days(VFD) 
Ventilator-free days, is a composite outcome that reflects duration of mechanical 
ventilation. For this investigation, VFD will be used to reflect appropriateness of energy 
intake prescription. The numbers of consecutive days after the endotracheal tube has 
been removed up to study day 28 constitute the absolute number of VFD. Removal of 
the endotracheal tube will be calculated from the first time the tube is continuously 
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absent for a minimum of 48 hours, with success defined as spontaneous breathing for 
24 hours without support of mechanical ventilation.61 We expect to see a difference 
between those nutrient prescriptions derived from IC measurements compared to 
prescriptions derived from prediction equation calculations. The difference we propose 
will manifest in a 20% increase in ventilator-free days in the study group compared to 
the control group. 
2) Decreased weight loss   
Adequate caloric intake should minimize weight loss. There is an association between 
cumulative energy deficit and decrease in weight-for-age z-score (0.06; 95% CI: 0.01 – 
0.1).30 Participant weight is obtained on admission to the PICU and followed throughout 
the study period. Although it is difficult to obtain weights during the course of acute, 
critical illness, we will follow the trend and determine change from admission through 
PICU discharge or study day 28, whichever occurs first.   
3) Decreased loss of lean body mass  
Appropriate energy intake should minimize loss of lean muscle mass. We expect that 
sustained, appropriate intake will result in minimal breakdown of endogenous protein 
stores. Hulst and colleagues30 demonstrate an association between cumulative energy 
deficit and decrease in mid-upper arm circumference z-score (0.07; 95% CI: 0.009 – 
0.1). We will follow anthropometric measurements to determine change in muscle 
mass during the 28-day study period.  
4) Decreased length of PICU hospitalization 
With the use of IC to direct prescription for energy needs, participants should receive 
appropriate intake during the PICU stay and experience a decrease in overall length of 
hospitalization.  Research has demonstrated that critically ill children who receive 
appropriate nutrition support demonstrate increased physiologic stability and an earlier 
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return to baseline health status, shortening the duration of the illness and decreasing 
the length of hospitalization.35 We hypothesize that critically ill children with ALI 
requiring mechanical ventilation who have energy needs assessed through the use of 
IC and nutrient prescription based on IC data will demonstrate improved physiologic 
status due to optimization of nutrition support, resulting in improved clinical outcomes 
and decreased length of hospitalization in comparison to those children whose nutrition 
was determined using standard prediction equations.   
Overall Analysis Plan 
Preparation of the Analysis Data Set   
All primary and secondary outcomes will undergo 100% data audit against the 
medical record. The data audit includes visual screening for missing data and 
inconsistencies. All out-of-range values, inconsistencies, and missing data will 
generate a query that will require examination of the participant’s medical record for 
resolution. Preplanned construction of new variables will be conducted in accordance 
with the study hypotheses and analysis plans. Variable transformation may be required 
for interpretation and statistical analysis purposes.   
Analysis Plan 
The primary outcome for this study is the number of VFD in the two groups. 
Secondary outcomes include a decreased loss of lean body mass (LBM) with weight 
maintenance (baseline to day 28) and length of hospitalization. The median number of 
VFD will be compared using the nonparametric Wilcoxon rank-sum (Mann-Whitney U) 
test. Categorical demographic variables will be analyzed using the Chi-square test, 
while differences in continuous demographic and secondary outcome variables (loss of 
lean body mass and length of hospitalization) will be assessed with the two-sample 
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Student t test (for normally distributed data) or the Wilcoxon rank-sum test (non-normal 
data). Baseline analysis will include the following:   
1.   Comparison of the two groups using descriptive statistics (measures of central 
tendency [means and medians] and dispersion [standard deviations and 
interquartile ranges] for continuous variables with frequency counts and marginal 
percentages for categorical variables) will be computed for all study variables and 
examined for marked skewing, outliers, and any systematic missing data. 
Transformations will be undertaken as required.  
2.   Pearson product intercorrelations will be computed and examined for 
multicollinearity.  
Statistical significance will be set at the 0.05 level based on the two-tailed alpha 
test.  Data analysis will be performed using SPSS (SPSS Inc., Chicago, IL) and 
SAS (SAS Institute, Inc., Cary, NC) statistical programs. 
Training of Study Personnel 
In the start-up phase (first 9 months of study year 1), all members of the study 
team will be trained on the study protocol. In addition, the PI will be trained and quality 
tested for reliability on use of the metabolic cart to perform the REE measurements.  
Both the PI and the RA will be trained and tested for reliability and reproducibility in 
obtaining skinfold measurements, overseen by Dr. Stallings. Procedures for screening 
of potential participants, family approach, and the consent and enrollment process will 
be developed and evaluated for completeness with support from Drs. Medoff-Cooper, 
Curley, and Srinivasan. The RA will be trained in participant screening, confirmation of 
eligibility, family approach and consent, data abstraction, and data entry into a 
password-secured database. RA activities will be directed and supervised by the PI. 
Table 3 depicts the proposed training and study timeline. 
 113 
 
Table 3 Estimated Timeline of Study Activity 
 
Responsible Conduct of Research 
 The PI has received and will continue to receive training on the ethical conduct 
of research through various resources available at the University of Pennsylvania. The 
University recognizes and takes responsibility for training the applicant in the area of 
responsible conduct of research.  The format for the education in the responsible 
conduct of research will vary. Members of the training team will be available for formal 
and informal problem-focused meetings. The applicant will meet face-to-face monthly 
with Dr. Barbara Medoff-Cooper, to  assure the understanding of informed consent, 
have the opportunity to observe and debrief the deliberations of two different IRBs and 
observe the peer review process. In addition, the applicant will have face-to-face 
meetings with Dr. Medoff-Cooper regarding the conduct of research with families and 
 Year 1 Year 2 Year 3 Year 4 Year 5 
Hire RA; Develop 
databases, operations 
manual, case report 
forms; Complete IRB 
process 
1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 
PI, RA training                     
Participant screening, 
enrollment, initiate 
protocol, data collection, 
data entry 
                    
Complete data entry, data 
cleaning; Preliminary data 
analysis 
                    
Final Data analysis                     
Dissemination of results                     
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vulnerable populations and to ensure protection of human subjects.   The PI will 
continue to participate in the University of Pennsylvania School of Nursing weekly 
Research Colloquia, which is conducted though the Office of Nursing Research. In 
addition, the PI will have access to monthly meetings in the Divisions of Family and 
Community Health and Biobehavioral Research at the School of Nursing. Topics of 
these hour-long sessions include, but are not limited to: conflict of interest (personal, 
professional, and financial), policies regarding human subjects, mentor/mentee 
responsibilities and relationships, collaborative research (including collaborations 
with industry), peer review, data acquisition and laboratory tools, scientific integrity, 
research misconduct (and policies for handling misconduct), responsible authorship 
and publication, contemporary ethical issues in biomedical research, the scientist as 
a responsible member of society, Federal Assurances, Internal Review Board (IRB) 
basics, monitoring grant spending research with vulnerable populations, and 
academic integrity.  
The PI has completed on-line education on HIPAA certification and Protection 
of Human Research Subjects- Biomedical, which satisfies the university’s requirement 
for human subjects’ research training in the biomedical sciences. In addition, the PI has 
completed the Subject Oriented Training in the School of Medicine. These modules 
include information on informed consent, vulnerable populations, records research, 
FDA regulated research, and conflicts of interest. In addition, the PI has completed 
courses in clinical and research ethics. Issues of responsible conduct are included in 
coursework of two research methods courses (quantitative and qualitative methods). 
These courses are required of the applicant during doctoral education.  
Protection of Human Subjects 
The study will seek recruitment of a representative proportion of males and  
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females indicative of the ethnic and racial distribution common to the PICU at CHOP.  
All participants will be children who are at least 44 weeks post-conceptual age, but 
have not yet had their 19th birthday, with a diagnosis of ALI and require mechanical 
ventilation.  The entire primary research team is trained and has extensive experience 
in the care and clinical management of critically ill infants, children and adolescents.  A 
member of the research team will be available to communicate with enrolled families 
and the PICU staff at all times to answer questions and explain procedures as 
necessary. Weekend and off-hours coverage will be on a rotating basis. 
Potential risks which would involve loss of lung volume during the IC 
measurement, will be minimized by strict adherence to the study protocol.  Should the 
participant exhibit signs of distress during IC measurement, the assessment will be 
aborted immediately.  A critical care provider, RRT and critical care nurse will be 
present at all times during IC measurement.  The patient will be continuously monitored 
by observation and electronic hemodynamic monitoring. 
Potential benefit to the participants randomized to the study group include 
precise prescription of energy needs to meet actual energy requirements with the 
potential to increase ventilator free days, decrease loss of lean muscle mass, maintain 
weight through critical illness, improve overall outcomes and decrease length of 
hospitalization. These potential benefits hold promise for clinical implementation and 
shift of clinical practice paradigms related to nutrition management for critically ill 
children with ALI requiring mechanical ventilation. Participants randomized to the 
control group will receive usual PICU care. The alternative to IC measurements to 
determine energy needs is usual PICU care and families can opt to withdraw from the 
protocol at any time, however all effort to maintain participation will be employed.  
There are no financial or legal risks for participation in this study.   
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Confidentiality 
To protect against any risk to participant confidentiality, all printed data forms 
will be coded with a unique anonymous identifier.  This unique identifier will be stored 
separately from files with personal health information (PHI) to maintain confidentiality.  
As part of the of the consent process, participants will be made aware that 
circumstances exist (regulatory or legal) where the research team will have to provide 
subject information to others.  Signed consent forms and other participant specific 
forms and documents will be labeled with the participant’s name, these forms along 
with a master list of participants will be secured separate from any information with PHI 
and identification numbers in locked cabinets away from the PICU.  Access will be 
limited to those directly involved with this study. Databases will be maintained on a 
secured, password-protected research quality network drive and maintained by the PI 
in accordance with the standards of the School of Nursing at the University of 
Pennsylvania and CHOP.  The scheduled back up procedures in accordance with each 
institution will be followed. Every effort to maintain participant information confidentiality 
will be employed.  All identifying data will be removed from files prior to electronic 
transfer to the biostatistician. No individual subjects will be identifiable from written or 
oral dissemination of the results of this study. 
Data Safety Monitoring 
There will be two levels of data and safety monitoring. The first level will be on-
site, a study monitor (PI or other member of the study team) will verify data integrity, 
compliance to the protocol and review source data and medical records, case report 
forms and regulatory documents for completeness, accuracy and legibility. 
Discrepancies will be discussed between the PI and study team as appropriate. The 
study team will collect all data and perform initial data entry. A verification of data entry 
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will then be performed by another member of the team. The second level of data and 
safety monitoring will be the establishment of a Data and Safety Monitoring Board 
(DSMB), which consists of individuals responsible for study oversight.  The DSMB 
members will be appointed by the PI with approval of the funding agency. The 
Research Institute at CHOP and the University of Pennsylvania will be provided 
names, and a summary of the background and expertise of the DSMB board members. 
The DSMB members will consist of three faculty members independent of the research 
team, two with expertise in pediatric critical care and one with expertise in 
interpretation and analysis of energy expenditure measurements.  
 All DSMB members will be appointed for the five study years.  They must disclose any 
conflict of interest with the present study. The DSMB board will have a Chair and 
Executive Secretary appointed.  The DSMB will monitor study regulatory files, 
enrollment tracking logs, informed consent forms, case report forms and overall study 
protocol. The board will meet at least annually for these activities. The PI will be 
responsible for scheduling the meetings and selecting items to be reviewed.   
Inclusion of Women, Minorities, and Children 
All participants in the study are children between post-conceptual age of 44 
weeks and prior to their 19th birthday. The anticipated sample will be racially diverse as 
CHOP serves a large local, regional, national and international community. Bi-weekly 
meetings with the research team will include discussions surrounding recruitment and 
retention of minority children.  Concurrently, the PI and RA will participate in the 
University of Pennsylvania, School of Nursing’s Culture and Diversity seminars. In the 
over 3000 annual admissions in the PICU at CHOP in the preceding year, the diversity 
distribution was 54% non-Hispanic White, 6.4% Hispanic, 28% African-American, 1.7% 
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Asian/Pacific Islanders, < 1% Native American and 10% Other / Unknown / Decline to 
Claim.  Gender distribution was 58% to 42% male to female respectively.  
Consortium Agreement 
The Pediatric Intensive Care Unit (PICU) at The Children’s Hospital of 
Philadelphia (CHOP) is a clinical, research facility were this randomized clinical trial 
would be conducted. 
Invertebrate Animals   
There is no use of animals or collection of data from animals in this study. 
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Chapter 4  
Summary and Conclusions 
 There is abundant evidence associating growth failure and infants with 
Congenital Heart Disease (CHD). This body of work further examines this relationship 
through an investigation of growth velocity and energy expenditure in a sample of 
infants with CHD following surgical intervention in early infancy.  Although there is 
debate clinically and in the literature on what constitutes growth failure in these infants, 
the studies presented in this dissertation illustrate a negative statistical difference in 
growth between infants with CHD and healthy infants. In addition, this data offers one 
potential explanation – inadequate energy intake. Use of the newly developed World 
Health Organization (WHO) child growth and growth velocity standards,1,2 make the 
studies presented here novel in their approach to investigate growth in these infants.  
Illustrating a difference in growth velocity compared to healthy infants and 
demonstrating that energy expenditure in infants with CHD is not different from healthy 
infants of the same age and gender, make this work is timely and important to the 
clinical care of these infants. The following is a summation of the research findings and 
their contribution to better understand growth failure in infants with CHD following 
surgery in the neonatal period. 
Specific Aims and Manuscript Review 
Growth Monitoring 
Growth Velocity 
 Growth velocity is the change over time in a given measure of physical 
development. It can have high variability reflecting a naturally occurring pattern of 
saltatory growth and catch-up or slow-down to account for a normal pattern of attained 
growth reflected on standard growth charts.2 The first study of this dissertation, “Growth 
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Velocity over the First Year of Life Following Neonatal Surgery for Congenital Heart 
Disease” is a descriptive study describing the pattern of growth velocity for weight, 
length and head circumference in a sample of infants with CHD following neonatal 
surgery compared to healthy infants of similar age and gender. These data 
demonstrate decreased growth velocity in infants with CHD compared to healthy 
infants.  Calculating and monitoring growth velocity growth is a more accurate way to 
assess short and long-term changes in growth measures based on the time intervals 
instead of a point in time.2,3  Using the WHO standards, which define growth based on 
international child health standards, weight, length and head circumference, z-scores 
and velocity z-scores were calculated. The standardized z-score measures clearly 
exhibited a difference at 3-months of age, depicting lower z-scores and a decreased 
rate of growth in infants with CHD.  Despite the decreased rate of growth seen at 3 
months of age, there was no difference in velocity z-scores for weight, length or head 
circumference for the remaining time intervals, suggesting that the growth disparity of 
early infancy is modifiable and that improved growth in infants with CHD is attainable. 
These data provide a foundation on which to build a definition of growth failure in 
infants with CHD.  However, small sample size and missing data prevent development 
of a definition based on this sample.  
 Although we measured growth velocity in 3-month intervals, the WHO growth 
velocity standards allow for surveillance in weekly intervals in early infancy.2 The use of 
these standards with close observation beginning at birth of attained growth and the 
rate of change in growth parameters are a means for early identification of infants at 
risk for poor growth. With early identification, early intervention is possible which can 
prevent or minimize the degree of growth failure and decrease the potential for long-
term morbidities that can result from poor growth in infancy.   
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 These data provide the platform for the design of strategies and interventions 
aimed at increased caloric intake to assess if growth failure demonstrated in this study 
by poor growth velocity is in fact modifiable.  A program of feeding strategies that 
supports an increase in energy intake may be the not so simple solution to this 
persistent problem.4-8 Ongoing concentrated efforts in nutrition support aligned with 
medical and nursing care may improve the rate of growth in infants with CHD to mirror 
that of healthy infants. Further, this study may be the prologue of an intervention study 
to develop and longitudinally test an intervention aimed at providing increased caloric 
intake and monitoring infant response through feeding tolerance and attained growth 
and growth velocity patterns. This may be a step at mitigating growth failure in infants 
with CHD following neonatal surgery. 
Energy Expenditure 
 The identification of differences in growth between infants with CHD and 
healthy infants demonstrated in the study on growth velocity, presents a logical 
progression to identify predictors of poor growth in these infants.  Increased energy 
expenditure related to cardiac physiology and the associated hemodynamic and 
metabolic status is hypothesized to be a contributing factor in growth failure in infants 
with CHD.  This is the focus of the second study presented in chapter 2, “Resting 
Energy Expenditure at 3-Months of Age in Infants Following Neonatal Surgery for 
Congenital Heart Disease”. The primary aim of the study was to determine differences 
in resting energy expenditure (REE), body composition and weight at 3-months of age 
in infants with CHD compared to healthy infants.  A secondary aim was to identify 
predictors of REE in the same population.  
Findings from this investigation reject the hypothesis that post surgical cardiac 
physiology is the primary component driving energy expenditure. Further, no difference 
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in REE was demonstrated between infants with CHD compared to healthy infants. In 
fact, fat free mass (FFM) and infant age were the strong predictors of REE Kcal/day in 
the study sample. Not only was cardiac physiology was not a primary causal factor, it 
was not a major contributor to REE kcal in this study sample.  
As expected, data from this study demonstrate FFM to be the primary predictor 
of REE kcal. There was no difference in REE kcal between infants with CHD and 
healthy infants, eliminating it, FFM, as contributing to poor growth in infants with CHD. 
Instead, this study demonstrated % body fat to be lower in infants with cardiac disease, 
which like accounts for their lower body weight in this study. This finding suggests 
energy intake is inadequate in infants with CHD since FM and therefore % body fat is 
directly related to caloric intake. Studies have shown poor nutrient intake during 
hospitalization, poor weight gain at hospital discharge, and reports of inconsistent 
feeding tolerance once home.4,9-11 The decreased accretion of fat demonstrated in this 
study at 3-months of age suggests that poor weight gain continues post hospital 
discharge.  This was an interesting finding as it further supports the hypothesis that 
consistent energy and nutrient intake are a challenge for infants with CHD and may be 
the basis for poor weight gain and subsequent growth failure. It was striking that the 
infants with CHD showed an increased REE difference of only 8 kcal/day compared to 
healthy infants, however, kg weight and WHO weight z-scores were significantly 
different between the groups. This is most likely explained by the significantly lower % 
body fat these infants exhibited.  Clinically, these findings suggest poor attained weight 
at 3-months of age is related to inadequate caloric intake and the inability of these 
infants to attain and sustain a positive energy balance that is necessary for fat and lean 
body mass accretion.  
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It is important to note that these findings did not indicate cardiac physiology to 
be a predictor for REE kcal in infants with CHD. This dispels the commonly held view 
that cardiac disease is the basis for growth failure these infants often exhibit. In 
addition, these findings support that idea that with focused concentrated nutrition 
support along with medical and nursing care, growth failure seen in early infancy is 
reversible and it is possible for these infant to attain their genetic growth potential.  
Similar to the study on growth velocity, these findings present a platform for a program 
of research investigating the unique feeding, energy and nutrient intake needs of 
infants with CHD.  Further, this study supports the idea of incremental measurements 
of body composition in these infants to assess their nutrition status by the amount of 
lean body mass compared to body fat mass, which can direct prescriptions for energy 
and nutrient intake.   
These studies examined questions focused on growth and nutrition status in 
infants with cardiac disease following neonatal surgery. They present important data 
that can be used as a platform for further inquiry and clinical practice. The introduction 
of the WHO growth and growth velocity standards for infants and children, provide 
excellent tools to further the inquiry surrounding growth and nutrition in clinical practice 
and research endeavors.12 The WHO standards have indices for weight, length, head 
circumference and growth velocity that have proven successful in the studies 
presented to evaluate growth. 1,2 The child growth and growth velocity standards can 
be useful for designing protocols and to identify specific parameters that can be used 
to define growth failure in infants with chronic illness such as CHD, however the 
studies presented suggest poor growth seen in early infancy is reversible and normal 
growth patterns for infants with CHD attainable.  
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These investigations of growth and growth failure in infants with CHD are 
important not only for somatic growth and its association with child health, but also for 
the sequela that is associated with poor growth.  Numerous associations exist between 
cognitive, neurodevelopmental and neurobehavioral deficits in children who have 
experienced poor growth in infancy.  In both the general pediatric literature and the 
pediatric cardiac literature, poor growth in infancy has the potential to have residual 
effects well into childhood. The work of this dissertation has elucidated information that 
potentially can intervene in growth failure in early infant and may in turn thwart the 
associated untoward cognitive and neurologic outcomes seen in childhood.  
Study Limitations 
The limitations presented here are relevant to both studies presented in 
Chapter 2. These include both studies are single center cohorts. This limits the 
generalizability of the findings but lays the groundwork for replication of each of the 
study protocols as larger clinical trials to determine reproducibility and generalizability 
of the study results. The study setting, The Children’s Hospital of Philadelphia (CHOP), 
may have a higher acuity of cardiac disease than that seen and treated in other 
centers. Therefore, study findings may not be applicable in all pediatric cardiac 
settings. Recruitment for both studies occurred approximately 8 years prior, with the 
changes in surgical approach and technology these study findings may have a 
decreased impact in the research community. Assessment of dietary intake was 
attempted but the Neither investigation had reliable dietary intake data available for 
analysis, which would have strengthened the results. Birth data was extracted from the 
transport record that accompanied the infant to CHOP leaving question to its reliability, 
and reducing any inference that can be made regarding growth and growth velocity 
between birth and 3-months of age. Information learned from the 3-month data in both 
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studies, indicate the time between hospital discharge and 3 months of age in infants 
with CHD may be crucial to better understanding growth issues in these infants. There 
may be bias in that the families that enrolled and participated were motivated and 
actively participated in the rigorous research protocol. Data is not available to address 
familial educational or socioeconomic status and whether this reflects or impacts study 
enrollment. Lastly, the study sample may not completely represent families with infants 
that had the most challenging hospital course and were therefore not willing to consent 
to study participation. These issues singularly or in combination, they may influence 
study results. 
NIH Director’s Early Independence Award Application 
 To move the science forward and to ‘translate’ the knowledge and skills 
obtained over the course of this dissertation work, a grant proposal was prepared and 
submitted to the National Institutes of Health (NIH) as a candidate for an Early 
independent Investigator award. This proposal entitled: “The Use of Indirect 
Calorimetry (IC) to Measure Energy Needs in Mechanically Ventilated Children with 
Acute Lung Injury”, represents a modified approach to translational research, 
addressing the adoption of best practice.13  As part of this dissertation, this proposal 
serves to demonstrate the importance of translation of knowledge to support the idea 
of best practice in the care of children. Through knowledge gained from the testing and 
analysis of energy expenditure in postsurgical infants with complex CHD, this 
application, designed as a clinical trial proposes to measure energy expenditure in 
critically ill children requiring mechanical ventilation. The goal of this proposed trial was 
to assess energy needs through the use of indirect calorimetry in children with acute 
lung injury requiring mechanical ventilation.  The specific aim of the proposed study is 
to measure energy expenditure using indirect calorimetry to assess and prescribe 
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caloric intake specific to energy needs as compared to standard current practice of 
prescribing energy intake from the use of prediction equation calculations. Research 
has shown that prediction equations often under or overestimate energy requirements, 
which can threaten clinical outcomes14-16.  In this dissertation work, the investigation of 
energy expenditure in infants with cardiac disease demonstrated the inaccuracy of 
prediction equations to estimate energy needs when compared to measured energy 
expenditure. This proposal exemplifies the need to further study measurement of 
energy expenditure and its impact on participant outcomes versus the use of 
equations.  
Many of the current therapies and much of our understanding of disease 
progression and appropriate treatment for children are derived from adult science.  
This practice can be challenging as knowledge is gained about differences between 
adults and children in their presentation and response to illness and treatment. 
This proposal exemplifies the importance of conducting research specific to infants and 
children to better understand pediatric response to illness, treat the unique needs of 
the pediatric population and improve care delivery and overall outcomes. This is 
particularly true in regards to energy needs, which can influence response to illness 
and has long-reaching consequences for optimal health. 
Future Research 
 The current body of work can move forward in two directions. The first would be 
to replicate the research presented to a larger sample and follow the cohort for a longer 
period. This would allow serial monitoring of growth measures, and the collection of 
more data points to better examine and understand growth and growth velocity in both 
healthy infants and those with CHD.  Data on nutrient intake during the study period 
will also improve understanding of growth and growth failure and can provide for 
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recommendations for caloric and nutrient intake, improve prescriptions for energy 
needs based on actual energy intake and expenditure, and provide for a better 
assessment of growth measures. This will better define growth, growth velocity and  
growth failure in infants with complex CHD relating their nutrient intake, nutrition status 
and growth parameters. This trajectory of research will establish a foundation to 
develop nutrition support programs for infants are at risk for growth failure. Initiating  
nutrition support programs can establish another tier of continued research to monitor 
program success with incremental assessments of growth, growth velocity, body 
composition and energy expenditure. 
 A second direction for future research would parallel the ideas outlined in the 
grant proposal. There is much to understand the nutritional needs of infants and young 
children during critical illness. With ongoing evidence that the prediction equations are 
inadequate, it follows that a more accurate method is necessary to address energy 
needs and prescription of appropriate energy and nutrient intake during critical illness. 
Measurement of caloric needs with prescription and delivery specific to those needs 
can be an adjunct to care in critically ill children and has potential to improve outcomes. 
In pediatric critical care, appropriate provision of energy and nutrients remains a 
challenge, both researchers and clinicians acknowledge meeting nutrition needs to be 
an important aspect of care during and immediately following hospitalization. Accurate 
nutrition prescriptions based on measured energy expenditure can decrease 
complications associated with inadequate nutrient intake in critical illness, i.e. weight 
loss, alteration in body composition, and length of hospitalization.  
 Based on work throughout this dissertation, the conceptual model introduced at 
the outset can be modified.  This work suggests energy balance is modifiable, and that 
modification can effect growth in infants with cardiac disease who have undergone 
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surgical intervention in the neonatal period. The possibilities for future nutrition and 
growth research born from this dissertation work abound and provide an exciting 
outlook for the direction of investigations in the care of infants and young children.  
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Figure 1 Modified Conceptual Model  
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Modified schematic of the concept of potential influences on growth in infants with CHD 
following surgical intervention in the neonatal period  
  
 140 
 
CLOSING 
 
Commencement May 16, 2011 
PhD Student Speaker Address: 
University of Pennsylvania, 
School of Nursing 
Kimmel Center, Philadelphia, PA 
 
LOOK AT US NOW 
Good Afternoon.  To Dean Meleis, Ms Greco, Dr Savard, Dr Shalala, esteemed faculty, 
honored guests, fellow graduates, family and friends: 
LOOK AT US NOW 
LOOK AT US.  To my graduating colleagues, you remember year “1”.  We were all 
sitting in Dr Julie Fairman’s class on the “Philosophy of Science in Nursing”.  You 
remember – we were told that we were about to have our brains unpacked, scrambled 
and then by graduation – sometime in the future, we would re-packed our brains with 
some of the same but also with enhanced and new knowledge. Who knew we would 
learn the language of post-modernism, empiricism, feminism, relativism and the 
like…Well – LOOK AT US NOW, the repacking has been a journey, but much easier 
than we thought… 
LOOK AT US NOW. Remember - “Concept Analysis” – some of us had to stretch, 
because to conceptualize we thought, was well beyond our reach, we provided care, it 
was tangible, not a concept… but, concept building, it was a part of the unpacking and 
the scrambling; we had yet to reach the repacking stage, so we needed a concept, a 
model on how to do it...  
LOOK AT US NOW. We have poked proteins; examined phthalates; uncovered 
properties of skin elasticity; cared for the elderly; scrutinized kidney disease;  held 
heart to heart talks with immigrants; used history to explore our nursing identity; 
examined symptom clusters in cancer; followed mothers and children with HIV;  
wacked on a few mice; probed into psychiatric assessment;  thought about sleep – 
while we were losing it; investigated the impact of vitamin D in diabetes; examined 
school performance in ex- preemies and studied the expenditure of energy in infants 
with congenital heart disease… In essence, we have repacked our brains and in doing 
so, we have added to the knowledge of nursing science, we are becoming 
epistemologists…LOOK AT US NOW! 
LOOK AT US – now we initiate and we lead the conversations on:  “the literature tells 
us”, “the research is lacking” and “recent data suggests”…that’s us talking and us 
saying those words!  LOOK AT US NOW! 
LOOK AT US – while we repack of our brains, we also pack tools…tools to pioneer 
new thought processes, tools to formulate new questions, tools to be a new wave of 
nurse scientist...tools with which we will build new knowledge – epistemologically 
speaking… 
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LOOK AT US NOW… to everyone here, go-ahead look around - remember these 
names and these faces for we are a generation of nurse scientists who are multi-
talented, and the world has just become our playground. 
So, everyone, take a look…look at this class of PhD graduates of the University of 
Pennsylvania, School of Nursing for 2011… But don’t blink or look away, because once 
you do, you will miss the continuation of the repacking, you will miss epistemology in 
the making… because along the way, we found out, the unpacking and repacking – it 
doesn’t end, it just changes.  We will forever unpack and repack – it is through that 
process that tools for continued growth and advancement develop, it is through that 
process that innovations and innovators – my graduating colleagues, are discovered… 
LOOK AT US NOW…I am humbled, proud and so very honored to have been 
nominated by you, my classmates to represent the 2011 PhD class…We walk out as 
newly graduated nurse scientists who have the ability to teach, to practice, to question 
and disseminate findings (please don’t forget to publish!)…and through the process we 
will continue to add to the knowledge of the science of nursing 
So, Dean Melesis, Ms Greco, Dr Savard, Dr Shalala, esteemed faculty, honored guests 
and friends – keep your eyes on us, WE ARE A FORCE!  
LOOK AT US NOW!!!  
Thank you. 
 
 
 
 
 
 
 
 
 
The Acquisition of Knowledge  
"The acquisition of knowledge is always of use to the intellect, because it may thus 
drive out useless things and retain the good. For nothing can be loved or hated unless 
it is first known."  
Leonardo da Vinci 
 
